<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Current Diabetes Reports via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Current Diabetes Reports' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Current+Diabetes+Reports&t=Current+Diabetes+Reports&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 15:08:51 +0100</lastBuildDate>
        <item>
            <title>Who Should We Target for Diabetes Prevention and Diabetes Risk Reduction?</title>
            <link>http://www.medworm.com/index.php?rid=5660414&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgqk11574u6185340%2F</link>
            <description>This article provides an overview of the current literature and is intentionally focused on the identification
 of high-risk populations (both adult and pediatric) that will help to address the key issues around the prevention of T2DM
 in health care settings.
 
 
	Content Type Journal ArticleCategory Translational Strategies for Diabetes Prevention (D Marrero, Section Editor)Pages 1-10DOI 10.1007/s11892-012-0255-xAuthors
		Susann Blüher, Leipzig University Medical Center, IFB AdiposityDiseases, University of Leipzig, Leipzig, GermanyJana Markert, Leipzig University Medical Center, IFB AdiposityDiseases, University of Leipzig, Leipzig, GermanySabine Herget, Leipzig University Medical Center, IFB AdiposityDiseases, University of Leipzig, Leipzig, GermanyThomas Yates, Department of Cardiova...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5660414</comments>
            <pubDate>Wed, 01 Feb 2012 17:10:50 +0100</pubDate>
            <guid isPermaLink="false">5660414</guid>        </item>
        <item>
            <title>Sweeteners and Risk of Obesity and Type 2 Diabetes: The Role of Sugar-Sweetened Beverages</title>
            <link>http://www.medworm.com/index.php?rid=5660415&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl6p21330501812p5%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Temporal patterns over the past three to four decades have shown a close parallel between the rise in added sugar intake and
 the global obesity and type 2 diabetes (T2D) epidemics. Sugar-sweetened beverages (SSBs), which include the full spectrum
 of soft drinks, fruit drinks, energy and vitamin water drinks, are composed of naturally derived caloric sweeteners such as
 sucrose, high fructose corn syrup, or fruit juice concentrates. Collectively they are the largest contributor to added sugar
 intake in the US diet. Over the past 10&amp;nbsp;years a number of large observational studies have found positive associations between
 SSB consumption and long-term weight gain and development of T2D and related metabolic conditions. Experimental studies provide
 insight into poten...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5660415</comments>
            <pubDate>Tue, 31 Jan 2012 07:05:05 +0100</pubDate>
            <guid isPermaLink="false">5660415</guid>        </item>
        <item>
            <title>Diabetes-Induced Birth Defects: What Do We Know? What Can We Do?</title>
            <link>http://www.medworm.com/index.php?rid=5515813&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft123xx5133v41x23%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Birth defects are the leading cause of infant mortality in the United States, which has one of the highest infant mortality
 rates in the developed world. Many of these birth defects can be attributed to pre-existing, or pregestational, diabetes in
 pregnancy, which significantly increases a mother’s risk of having a child with a major birth defect. Strict preconceptional
 and early pregnancy glucose control, supplementation with multivitamins and fatty acids, and lower glycemic dietary management
 have been shown to reduce the incidence of birth defects in experimental and epidemiologic studies. However, because more
 than half of pregnancies are unplanned, these methods are not generalizable across the population. Thus, better interventions
 are urgently needed. Bas...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515813</comments>
            <pubDate>Wed, 14 Dec 2011 06:57:30 +0100</pubDate>
            <guid isPermaLink="false">5515813</guid>        </item>
        <item>
            <title>The Adjectives of Inpatient Glycemic Management</title>
            <link>http://www.medworm.com/index.php?rid=5495217&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9738j512315222v0%2F</link>
            <description>Content Type Journal ArticleCategory Invited CommentaryPages 1-3DOI 10.1007/s11892-011-0250-7Authors
		Jodie Reider, Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh, PA, USAMary T. Korytkowski, Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5495217</comments>
            <pubDate>Thu, 08 Dec 2011 07:21:18 +0100</pubDate>
            <guid isPermaLink="false">5495217</guid>        </item>
        <item>
            <title>Determining Genetic Risk Factors for Pediatric Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5477101&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp2112168950v2376%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The prevalence of type 2 diabetes (T2D) is increasing significantly in the pediatric population. A strong family history of
 the disease suggests the involvement of genetic factors for diabetes development, but defining the molecular genetics of T2D
 in children is difficult due to a low number of subjects and the lack of robust diagnostic criteria. Thus, genetic studies
 of T2D have been carried out almost exclusively in adults. In this review, the genetics of T2D is summarized and options for
 discovering the missing heritability explored. The review concludes with a discussion of future research that will be required
 for determining genetic risk factors for pediatric T2D.
 
 
	Content Type Journal ArticleCategory Pediatric Type 2 Diabetes (M Freemark, Section Editor...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477101</comments>
            <pubDate>Fri, 02 Dec 2011 18:09:51 +0100</pubDate>
            <guid isPermaLink="false">5477101</guid>        </item>
        <item>
            <title>Type 2 Diabetes in Childhood: Clinical Characteristics and Role of β-Cell Autoimmunity</title>
            <link>http://www.medworm.com/index.php?rid=5477100&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy0q1861677064353%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The global obesity epidemic has led to dramatic increases in the incidence and prevalence of type 2 diabetes mellitus (T2DM)
 among youth worldwide. In today’s clinical practice it has become increasingly difficult to distinguish type 1 diabetes mellitus
 (T1DM) from T2DM as many children with T1DM are overweight at diagnosis. Numerous recent publications note a significant proportion
 of physician-diagnosed T2DM youth with evidence of pancreatic autoimmunity, exemplifying the challenges in distinguishing
 between T1DM and T2DM. The clinical implications of the phenomenon of antibody positivity in phenotypic T2DM youth, also referred
 to as “type 1.5 diabetes” (T1.5 DM), “double diabetes,” “latent autoimmune diabetes in youth” (LADY), and “hybrid diabete...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477100</comments>
            <pubDate>Fri, 02 Dec 2011 18:09:51 +0100</pubDate>
            <guid isPermaLink="false">5477100</guid>        </item>
        <item>
            <title>Management of Diabetes in Pregnancy</title>
            <link>http://www.medworm.com/index.php?rid=5477102&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F78k65m35q41h4177%2F</link>
            <description>This article emphasizes the newest guidelines for diabetes
 screening in pregnancy while reviewing their potential impact on maternal and neonatal complications that arise in the setting
 of hyperglycemia in pregnancy.
 
 
	Content Type Journal ArticleCategory Diabetes and Pregnancy (CJ Homko, Section Editor)Pages 1-10DOI 10.1007/s11892-011-0249-0Authors
		Jerasimos Ballas, Reproductive Medicine Department, University of California San Diego, 200 West Arbor Drive, San Diego, CA, USAThomas R. Moore, Reproductive Medicine Department, University of California San Diego, 200 West Arbor Drive, San Diego, CA, USAGladys A. Ramos, Reproductive Medicine Department, University of California San Diego, 200 West Arbor Drive, San Diego, CA, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-08...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477102</comments>
            <pubDate>Fri, 02 Dec 2011 18:09:50 +0100</pubDate>
            <guid isPermaLink="false">5477102</guid>        </item>
        <item>
            <title>Metabolic Programming, Epigenetics, and Gestational Diabetes Mellitus</title>
            <link>http://www.medworm.com/index.php?rid=5469477&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft82x1672j128v826%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The link between an adverse intrauterine environment and the development of disease later in life has been observed in offspring
 of pregnancies complicated by obesity and diabetes, but the molecular mechanisms underlying this phenomenon are unknown. In
 this review, we highlight recent publications exploring the role of gestational diabetes mellitus in the programming of disease
 in the offspring. We also review recent publications aiming to identify mechanisms responsible for the “programming effect”
 that results from exposure to diabetes in utero. Finally, we highlight research on the role of epigenetic regulation of gene expression in an animal model of uteroplacental
 insufficiency where the offspring develop diabetes as a model by which an exposure to the mot...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5469477</comments>
            <pubDate>Wed, 30 Nov 2011 04:53:30 +0100</pubDate>
            <guid isPermaLink="false">5469477</guid>        </item>
        <item>
            <title>Pathogenesis and Prevention of Type 2 Diabetes: Parental Determinants, Breastfeeding, and Early Childhood Nutrition</title>
            <link>http://www.medworm.com/index.php?rid=5458567&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa374714858015526%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Among the factors predisposing to type 2 diabetes in children, adolescents, and young adults, the health and behavior of both
 the mother and father are critical. Prevention and treatment of parental nutritional disorders (including obesity and malnutrition),
 promotion of breastfeeding, and avoidance of overfeeding of young children are essential for childhood health and metabolic
 function. Focusing research and policy on parental influences on childhood health should reduce the risks of obesity and type
 2 diabetes in future generations.
 
 
	Content Type Journal ArticleCategory Pediatric Type 2 Diabetes (M Freemark, Section Editor)Pages 1-6DOI 10.1007/s11892-011-0246-3Authors
		Sarah Bartz, Division of Pediatric Endocrinology and Diabetes, Duke University Medical Ce...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5458567</comments>
            <pubDate>Mon, 28 Nov 2011 16:58:14 +0100</pubDate>
            <guid isPermaLink="false">5458567</guid>        </item>
        <item>
            <title>Insulin Pumps in Pregnancy: Using Technology to Achieve Normoglycemia in Women with Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5441622&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq1v550w4015t0p02%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Poorly controlled diabetes before conception and during pregnancy among women with pre-existing diabetes can cause major birth
 defects and spontaneous abortions, as wells as abnormal fetal growth and development including an offspring who is small or
 large for gestational age, or predisposed to obesity, type 2 diabetes, and metabolic syndrome in his/her lifetime. Conversely,
 for a woman with pre-existing diabetes, optimizing blood glucose levels before and during early pregnancy can reduce these
 risks dramatically. As insulin pump technology has evolved, continuous subcutaneous insulin infusion has become a safe and
 reliable method for treating diabetes during pregnancy. Although pump therapy is often preferred by patients and some experts,
 insulin pumps have not ...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5441622</comments>
            <pubDate>Mon, 21 Nov 2011 18:05:40 +0100</pubDate>
            <guid isPermaLink="false">5441622</guid>        </item>
        <item>
            <title>The Placenta and Gestational Diabetes Mellitus</title>
            <link>http://www.medworm.com/index.php?rid=5432239&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj74350724m327746%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;By its location between maternal and fetal bloodstreams the human placenta not only handles the materno-fetal transport of
 nutrients and gases, but may also be exposed to intrauterine conditions adversely affecting placental and fetal development.
 Such adverse conditions exist in pregnancies complicated by gestational diabetes mellitus (GDM), and have been associated
 with alterations in placental anatomy and physiology. These alterations are mainly based on changes on the micro-anatomical
 and/or even molecular level including aberrant villous vascularization, a disbalance of vasoactive molecules, and enhanced
 oxidative stress. The consequence thereof may be impaired fetal oxygenation and changes in transplacental nutrient supply.
 Although transplacental glucose fl...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5432239</comments>
            <pubDate>Fri, 18 Nov 2011 17:31:37 +0100</pubDate>
            <guid isPermaLink="false">5432239</guid>        </item>
        <item>
            <title>Care of the Infant of the Diabetic Mother</title>
            <link>http://www.medworm.com/index.php?rid=5432240&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F442t7676729kh801%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Gestational diabetes mellitus (GDM) from all causes of diabetes is the most common medical complication of pregnancy and is
 increasing in incidence, particularly as type 2 diabetes continues to increase worldwide. Despite advances in perinatal care,
 infants of diabetic mothers (IDMs) remain at risk for a multitude of physiologic, metabolic, and congenital complications
 such as preterm birth, macrosomia, asphyxia, respiratory distress, hypoglycemia, hypocalcemia, hyperbilirubinemia, polycythemia
 and hyperviscosity, hypertrophic cardiomyopathy, and congenital anomalies, particularly of the central nervous system. Overt
 type 1 diabetes around conception produces marked risk of embryopathy (neural tube defects, cardiac defects, caudal regression
 syndrome), whereas lat...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5432240</comments>
            <pubDate>Fri, 18 Nov 2011 07:01:42 +0100</pubDate>
            <guid isPermaLink="false">5432240</guid>        </item>
        <item>
            <title>Glycemic Targets and Approaches to Management of the Patient with Critical Illness</title>
            <link>http://www.medworm.com/index.php?rid=5422733&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fun753g03w561t420%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hyperglycemia during critical illness is associated with adverse outcome. The proof-of-concept Leuven studies assessed causality,
 and revealed that targeting strict normoglycemia (80–110&amp;nbsp;mg/dL) with insulin improved outcome compared with tolerating hyperglycemia
 to the renal threshold (215&amp;nbsp;mg/dL). A large multicenter trial (NICE-SUGAR [Normoglycaemia in Intensive Care Evaluation and
 Survival Using Glucose Algorithm Regulation]) found an intermediate blood glucose target (140–180&amp;nbsp;mg/dL) safer than targeting
 normoglycemia. Differences in design and in execution of glycemic control at the bedside may have contributed to these results.
 In NICE-SUGAR (Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation), the blo...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5422733</comments>
            <pubDate>Wed, 16 Nov 2011 16:43:22 +0100</pubDate>
            <guid isPermaLink="false">5422733</guid>        </item>
        <item>
            <title>Management of Hyperglycemia During the Perioperative Period</title>
            <link>http://www.medworm.com/index.php?rid=5422734&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6172765212x2154v%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hyperglycemia is frequently encountered in the inpatient setting and is distinctly associated with poor clinical outcomes.
 Recent literature suggests an association between stringent glycemic control and increased mortality, thus keeping optimal
 glycemic targets a relevant subject of debate. In the surgical population, hyperglycemia with or without diabetes mellitus
 may be unrecognized. Factors contributing to hyperglycemia in the hospital include critical illness, use of certain drugs,
 use of enteral or parenteral nutrition, and variability in oral or nutritional intake as can occur when patients are prepared
 for procedures or surgery. A sensible approach to managing hyperglycemia in this population includes preoperative recognition
 of diabetes mellitus and risks...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5422734</comments>
            <pubDate>Tue, 15 Nov 2011 16:57:32 +0100</pubDate>
            <guid isPermaLink="false">5422734</guid>        </item>
        <item>
            <title>Gestational Diabetes: Implications for Cardiovascular Health</title>
            <link>http://www.medworm.com/index.php?rid=5361535&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnl74171h86371548%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Gestational diabetes mellitus (GDM) is a pregnancy complication that is becoming more prevalent with recent population trends
 in obesity and advancing maternal age. A diagnosis of GDM not only increases risk for maternal and fetal complications during
 pregnancy, but also significantly increases a woman’s risk of both type 2 diabetes mellitus (T2DM) and cardiovascular disease
 (CVD) in the postpartum. Even women with milder forms of abnormal glucose homeostasis during pregnancy, specifically gestational
 impaired glucose tolerance, are at increased risk, justifying the recent recommendation to tighten the diagnostic criteria
 for GDM, thus implicating many more women. Risk factors that increase risk for future CVD among women with a history of GDM
 include postpartum...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361535</comments>
            <pubDate>Sat, 29 Oct 2011 05:43:31 +0100</pubDate>
            <guid isPermaLink="false">5361535</guid>        </item>
        <item>
            <title>Basal-Bolus Insulin Protocols Enter the Computer Age</title>
            <link>http://www.medworm.com/index.php?rid=5348482&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm2p1566076631243%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Diabetes affects approximately one quarter of all hospitalized patients. Poor inpatient glycemic control has been associated
 with increased risk for multiple adverse events including surgical site infections, prolonged hospital length of stay, and
 mortality. Inpatient glycemic control protocols based on physiologic basal-bolus insulin regimens have been shown to improve
 glycemia and clinical outcomes and are recommended by the American Diabetes Association, the American Association of Clinical
 Endocrinologists, and the Society of Hospital Medicine for inpatient glycemic management of noncritically ill patients. The
 2009 Health Information Technology for Economic and Clinical Health (HITECH) Act will catalyze widespread computerized medication
 order entry implement...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5348482</comments>
            <pubDate>Thu, 20 Oct 2011 15:53:44 +0100</pubDate>
            <guid isPermaLink="false">5348482</guid>        </item>
        <item>
            <title>Flavor Learning In Utero and Its Implications for Future Obesity and Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5348483&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe733321500v2w3g7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The concept of prenatal flavor learning can be used to motivate women to eat healthy foods. The flavors of the foods in the
 maternal diet are found in the amniotic fluid swallowed by the fetus, with the fetus developing a preference for those flavors
 that is shown to persist in infancy. Furthermore, flavor preferences in infancy can persist into childhood and even into adulthood.
 Thus, the intrauterine environment may have a life-long influence on flavor preferences and healthy eating. This is an empowering
 concept for a pregnant woman: her baby will develop a preference for what she eats. However, education alone about this concept
 may not be sufficient to motivate behavior change. The evidence for health promotion strategies demonstrated to be effective
 in pregn...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5348483</comments>
            <pubDate>Thu, 20 Oct 2011 06:04:42 +0100</pubDate>
            <guid isPermaLink="false">5348483</guid>        </item>
        <item>
            <title>Medical Nutrition Therapy in Hospitalized Patients with Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5324424&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fal670l5x213vw2qk%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Medical nutrition therapy (MNT) plays an important role in management of hyperglycemia in hospitalized patients with diabetes
 mellitus. The goals of inpatient MNT are to optimize glycemic control, to provide adequate calories to meet metabolic demands,
 and to create a discharge plan for follow-up care. All patients with and without diabetes should undergo nutrition assessment
 on admission with subsequent implementation of physiologically sound caloric support. The use of a consistent carbohydrate
 diabetes meal-planning system has been shown to be effective in facilitating glycemic control in hospitalized patients with
 diabetes. This system is based on the total amount of carbohydrate offered rather than on specific calorie content at each
 meal, which facilitates m...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5324424</comments>
            <pubDate>Thu, 13 Oct 2011 15:48:36 +0100</pubDate>
            <guid isPermaLink="false">5324424</guid>        </item>
        <item>
            <title>Neonatal Diabetes: An Expanding List of Genes Allows for Improved Diagnosis and Treatment</title>
            <link>http://www.medworm.com/index.php?rid=5315199&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc2806381660754j8%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There has been major progress in recent years uncovering the genetic causes of diabetes presenting in the first year of life.
 Twenty genes have been identified to date. The most common causes accounting for the majority of cases are mutations in the
 genes encoding the two subunits of the ATP-sensitive potassium channel (KATP), KCNJ11 and ABCC8, and the insulin gene (INS), as well as abnormalities in chromosome 6q24. Patients with activating mutations in KCNJ11 and ABCC8 can be treated with oral sulfonylureas in lieu of insulin injections. This compelling example of personalized genetic medicine
 leading to improved glucose regulation and quality of life may—with continued research—be repeated for other forms of neonatal
 diabetes in the future.
 
 
	Content Type J...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5315199</comments>
            <pubDate>Wed, 12 Oct 2011 16:06:47 +0100</pubDate>
            <guid isPermaLink="false">5315199</guid>        </item>
        <item>
            <title>Genetic Determinants of Variability in Glycated Hemoglobin (HbA1c) in Humans: Review of Recent Progress and Prospects for Use in Diabetes Care</title>
            <link>http://www.medworm.com/index.php?rid=5305014&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr6877323457754m5%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Glycated hemoglobin A1c (HbA1c) indicates the percentage of total hemoglobin that is bound by glucose, produced from the nonenzymatic chemical modification
 by glucose of hemoglobin molecules carried in erythrocytes. HbA1c represents a surrogate marker of average blood glucose concentration over the previous 8 to 12&amp;nbsp;weeks, or the average lifespan
 of the erythrocyte, and thus represents a more stable indicator of glycemic status compared with fasting glucose. HbA1c levels are genetically determined, with heritability of 47% to 59%. Over the past few years, inroads into understanding genetic
 predisposition by glycemic and nonglycemic factors have been achieved through genome-wide analyses. Here I review current
 research aimed at discovering genetic determinants of...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5305014</comments>
            <pubDate>Thu, 06 Oct 2011 05:48:21 +0100</pubDate>
            <guid isPermaLink="false">5305014</guid>        </item>
        <item>
            <title>The Molecular Genetics of Sulfonylurea Receptors in the Pathogenesis and Treatment of Insulin Secretory Disorders and Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5297475&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd17m001810617739%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Sulfonylurea receptors (SURs) form an integral part of the ATP-sensitive potassium (KATP) channel complex that is present in most excitable cell types. KATP channels couple cellular metabolism to electrical activity and provide a wide range of cellular functions including stimulus
 secretion coupling in pancreatic β cells. KATP channels are composed of SURs and inward rectifier potassium channel (Kir6.x) subunits encoded by the ABCC8/9 and KCNJ8/11 genes, respectively. Recent advances in the genetics, molecular biology, and pharmacology of SURs have led to an increased
 understanding of these channels in the etiology and treatment of rare genetic insulin secretory disorders. Furthermore, common
 genetic variants in these genes are associated with an increased risk for ...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5297475</comments>
            <pubDate>Tue, 04 Oct 2011 05:56:00 +0100</pubDate>
            <guid isPermaLink="false">5297475</guid>        </item>
        <item>
            <title>Mobile Intervention Design in Diabetes: Review and Recommendations</title>
            <link>http://www.medworm.com/index.php?rid=5286309&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6t71j170l66l733j%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mobile technology enhances the potential to assess, prompt, educate, and engage individuals with diabetes. The near-ubiquitous
 presence of mobile phones allows real-time contextually relevant support for diabetes self-care. We review the design of mobile
 interventions included in a recent meta-analysis. Although mobile programs can lead to improvements in glycemic control, many
 aspects, such as the role of the diabetes clinician, real-time features, and patient engagement have not been documented.
 Studies with the greatest impact on hemoglobin A1c integrated patient feedback and a role for clinicians. Research is needed regarding feasible and efficacious roles for clinical
 support in mobile interventions. Recommendations for design and research include the followin...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5286309</comments>
            <pubDate>Fri, 30 Sep 2011 05:52:17 +0100</pubDate>
            <guid isPermaLink="false">5286309</guid>        </item>
        <item>
            <title>Building a Pipeline of Training for Behavioral Diabetes Researchers and Clinicians: A Call for National Dialogue</title>
            <link>http://www.medworm.com/index.php?rid=5286310&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft136576028155m5v%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In the context of a diabetes epidemic and health care workforce crisis in the United States, a national dialogue is needed
 to identify the pathways and mechanisms for training a cohort of behavioral diabetes researchers and clinicians. Over the
 past 40&amp;nbsp;years, the field of behavioral diabetes in the United States has emerged from a coalition of individual clinicians
 and researchers to a specialty field. At present, additional strategies are needed to expand the workforce to keep pace with
 the increasing prevalence of diabetes and the changing demographic trends. We review the training resources currently available
 and outline the challenges to trainees at all stages of career development. Recommendations include the following: establishing
 a Task Force for Beh...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5286310</comments>
            <pubDate>Thu, 29 Sep 2011 06:17:34 +0100</pubDate>
            <guid isPermaLink="false">5286310</guid>        </item>
        <item>
            <title>Methodological Issues in the Assessment of Diabetes Treatment Adherence</title>
            <link>http://www.medworm.com/index.php?rid=5286311&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr625g7q7jv457364%2F</link>
            <description>This article provides an overview of the literature on diabetes medication
 adherence, with a focus on measurement issues. We also consider work conducted in other chronic illnesses, particularly HIV/AIDS,
 that may have value in guiding future directions of diabetes medication adherence research. We highlight the need for focused
 investigation on how characteristics of self-report methodologies affect the validity of patient responses and conclude with
 practical recommendations based on the current state of the science.
 
 
	Content Type Journal ArticleCategory Psychosocial Aspects (Korey Hood, Section Editor)Pages 1-8DOI 10.1007/s11892-011-0229-4Authors
		Jeffrey S. Gonzalez, Ferkauf Graduate School of Psychology, Yeshiva University, New York, NY, USAHavah E. Schneider, Ferkauf Graduat...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5286311</comments>
            <pubDate>Thu, 29 Sep 2011 06:17:33 +0100</pubDate>
            <guid isPermaLink="false">5286311</guid>        </item>
        <item>
            <title>A Methodological Perspective on Genetic Risk Prediction Studies in Type 2 Diabetes: Recommendations for Future Research</title>
            <link>http://www.medworm.com/index.php?rid=5274550&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl0177102v7540310%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Fueled by the successes of genome-wide association studies, numerous studies have investigated the predictive ability of genetic
 risk models in type 2 diabetes. In this paper, we review these studies from a methodological perspective, focusing on the
 variables included in the risk models as well as the study designs and populations investigated. We argue and show that differences
 in study design and characteristics of the study population have an impact on the observed predictive ability of risk models.
 This observation emphasizes that genetic risk prediction studies should be conducted in those populations in which the prediction
 models will ultimately be applied, if proven useful. Of all genetic risk prediction studies to date, only a few were conducted
 in popul...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5274550</comments>
            <pubDate>Tue, 27 Sep 2011 05:46:17 +0100</pubDate>
            <guid isPermaLink="false">5274550</guid>        </item>
        <item>
            <title>Digging Deeper: The Role of Qualitative Research in Behavioral Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5238593&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6722p43g35224707%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Qualitative research methodology is more recognized and valued in diabetes behavioral research in recent years. Qualitative
 methods help clinicians answer questions that quantitative research may not be able to answer, such as exploring patients’
 motivations, perceptions, and expectations. This paper reviews recent (2005–present) rigorous qualitative studies of children,
 adolescents, and adult patients with type 1 and type 2 diabetes with the aim of answering the following research question:
 How has qualitative research contributed to our understanding of behavioral diabetes care? We focus on studies exploring patients’,
 health care providers’, and families’ interpersonal experiences of diabetes as well as patients’ psychosocial experiences
 of diagnosi...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5238593</comments>
            <pubDate>Mon, 19 Sep 2011 15:40:27 +0100</pubDate>
            <guid isPermaLink="false">5238593</guid>        </item>
        <item>
            <title>The Use of HbA1c for the Diagnosis of Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5226859&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw7268225w6v27871%2F</link>
            <description>Content Type Journal ArticleCategory Invited CommentaryPages 1-2DOI 10.1007/s11892-011-0228-5Authors
		Enzo Bonora, Endocrinology, Diabetes and Metabolism, University and University Hospital of Verona, Piazzale Stefani 1, I-37126 Verona, Italy
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5226859</comments>
            <pubDate>Fri, 16 Sep 2011 16:42:37 +0100</pubDate>
            <guid isPermaLink="false">5226859</guid>        </item>
        <item>
            <title>Sulfonylureas or Dipeptidyl Peptidase (DPP-4) Inhibitors in the Management of Type 2 Diabetes: Debate is Not yet Closed</title>
            <link>http://www.medworm.com/index.php?rid=5226860&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq3443v2k05832603%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-2DOI 10.1007/s11892-011-0227-6Authors
		Pierre-Jean Guillausseau, University Denis-Diderot Paris 7, Paris, France
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5226860</comments>
            <pubDate>Wed, 14 Sep 2011 05:45:04 +0100</pubDate>
            <guid isPermaLink="false">5226860</guid>        </item>
        <item>
            <title>Genetics of the HLA Region in the Prediction of Type 1 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5226861&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc2804p0607134p18%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Type 1 diabetes (T1D) is one of the most widely studied complex genetic disorders, and the genes in HLA are reported to account
 for approximately 40–50% of the familial aggregation of T1D. The major genetic determinants of this disease are polymorphisms
 of class II HLA genes encoding DQ and DR. The DR-DQ haplotypes conferring the highest risk are DRB1*03:01-DQA1*05:01-DQB1*02:01 (abbreviated “DR3”) and DRB1*04:01/02/04/05/08-DQA1*03:01-DQB1*03:02/04 (or DQB1*02; abbreviated “DR4”). The risk is much higher for the heterozygote formed by these two haplotypes (OR = 16.59; 95% CI,
 13.7–20.1) than for either of the homozygotes (DR3/DR3, OR = 6.32; 95% CI, 5.12–7.80; DR4/DR4, OR = 5.68; 95% CI, 3.91). In
 addition, some haplotypes confer strong pr...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5226861</comments>
            <pubDate>Mon, 12 Sep 2011 15:53:27 +0100</pubDate>
            <guid isPermaLink="false">5226861</guid>        </item>
        <item>
            <title>Reply to the letter by P. Guillausseau Regarding “Sulfonylureas or Dipeptidyl Peptidase (DPP-4) Inhibitors in the Management of Type 2 Diabetes: Debate Is Not Yet Closed”</title>
            <link>http://www.medworm.com/index.php?rid=5209646&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg141k11g3l80v563%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-1DOI 10.1007/s11892-011-0225-8Authors
		Bo Ahrén, Department of Clinical Sciences Lund, Lund University, B11 BMC, SE-221 84 Lund, Sweden
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5209646</comments>
            <pubDate>Fri, 09 Sep 2011 16:46:09 +0100</pubDate>
            <guid isPermaLink="false">5209646</guid>        </item>
        <item>
            <title>Gene × Environment Interactions in Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5196769&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg44243m58v1080j6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;People vary genetically in their susceptibility to the effects of environmental risk factors for many diseases. Genetic variation
 also underlies the extent to which people respond appropriately to clinical therapies. Defining the basis to the interactions
 between the genome and the environment may help elucidate the biologic basis to diseases such as type 2 diabetes, as well
 as help target preventive therapies and treatments. This review examines 1) some of the most current evidence on gene × environment
 interactions in relation to type 2 diabetes; 2) outlines how the availability of information on gene × environment interactions
 might help improve the prevention and treatment of type 2 diabetes; and 3) discusses existing and emerging strategies that
 might enhan...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5196769</comments>
            <pubDate>Fri, 02 Sep 2011 05:52:40 +0100</pubDate>
            <guid isPermaLink="false">5196769</guid>        </item>
        <item>
            <title>Family Interaction in Pediatric Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5162818&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp117hph0r5884j33%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Adaptation to type 1 diabetes is optimized in the presence of ongoing family support and supervision. Therefore, it is particularly
 important to understand how family interactions influence adaptation to the illness. The purpose of this paper is to review
 the current literature on family interaction in youth with type 1 diabetes. Recent advancements in the literature include
 greater specificity of types of parental involvement, attention to the role of fathers, acknowledgment of the impact of parental
 distress, increased use of observational methods, and awareness of the impact of culture. Continued parental involvement—particularly
 monitoring—in the management of diabetes care is important as children transition into adolescence, and the best outcomes
 are evi...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5162818</comments>
            <pubDate>Fri, 19 Aug 2011 06:23:14 +0100</pubDate>
            <guid isPermaLink="false">5162818</guid>        </item>
        <item>
            <title>Does Metformin Work for Everyone? A Genome-wide Association Study for Metformin Response</title>
            <link>http://www.medworm.com/index.php?rid=5162819&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk4207hr06x113648%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportPages 1-3DOI 10.1007/s11892-011-0220-0Authors
		Jose C. Florez, Center for Human Genetic Research/Diabetes Unit, Massachusetts General Hospital, Simches Research Building-CPZN 5.250, 185 Cambridge Street, Boston, MA 02114, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5162819</comments>
            <pubDate>Tue, 16 Aug 2011 06:17:00 +0100</pubDate>
            <guid isPermaLink="false">5162819</guid>        </item>
        <item>
            <title>Taking Evidence-Based Coping Skills Training to the Internet</title>
            <link>http://www.medworm.com/index.php?rid=5132655&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F76552v5151021546%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s11892-011-0221-zAuthors
		Marisa E. Hilliard, Center for Treatment Adherence, Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, MLC 7039, Cincinnati, OH 45229, USAKorey K. Hood, Center for Treatment Adherence, Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, MLC 7039, Cincinnati, OH 45229, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5132655</comments>
            <pubDate>Sat, 13 Aug 2011 06:05:58 +0100</pubDate>
            <guid isPermaLink="false">5132655</guid>        </item>
        <item>
            <title>State of the Art of Clinical Islet Transplantation and Novel Protocols of Immunosuppression</title>
            <link>http://www.medworm.com/index.php?rid=5120241&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F35303304x46722r2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Clinical islet transplantation has transitioned from curiosity to realistic therapy over the past decade. An estimated 750
 patients have undergone intraportal islet-alone transplantation over this period, and a smaller subset received combined islet-kidney
 transplants. The primary benefit of successful islet transplantation has been to eliminate severe, recurrent hypoglycemia,
 a problem that has been hard to eliminate by other means in 15% of those with type 1 diabetes. The secondary benefit of independence
 from insulin has attracted patients, but has had limited sustainability previously, especially with a single-donor graft,
 but recent results from four independent centers suggest marked improvement in long-term outcome, with 5-year results now
 approximating sol...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120241</comments>
            <pubDate>Wed, 10 Aug 2011 15:43:46 +0100</pubDate>
            <guid isPermaLink="false">5120241</guid>        </item>
        <item>
            <title>Immunoisolation of Pancreatic Islet Grafts with No Recipient’s Immunosuppression: Actual and Future Perspectives</title>
            <link>http://www.medworm.com/index.php?rid=5120242&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1183072157526046%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In spite of steady and remarkable progress, islet transplantation in patients with type 1 diabetes mellitus (T1DM) continues
 to face two major bottlenecks: inadequate availability of human pancreatic donors and necessity to totally immunosuppress
 the graft recipients lifelong. Microencapsulation of the islet grafts within highly biocompatible and selective permeable
 biomembranes could obviate use of the immunosuppressants, while potentially offering the opportunity to use a wide array of
 insulin-producing cells, in active development, including xenogeneic pig islets. Although macrodevices and microcapsules,
 which essentially differ by size/configuration, and both serve for immunoisolation devices, have been used for many years
 with initial human applications, new ...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120242</comments>
            <pubDate>Mon, 08 Aug 2011 19:51:47 +0100</pubDate>
            <guid isPermaLink="false">5120242</guid>        </item>
        <item>
            <title>Pig-to-Nonhuman Primates Pancreatic Islet Xenotransplantation: An Overview</title>
            <link>http://www.medworm.com/index.php?rid=5098414&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd70280480317p556%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The therapy of type 1 diabetes is an open challenging problem. The restoration of normoglycemia and insulin independence in
 immunosuppressed type 1 diabetic recipients of islet allotransplantation has shown the potential of a cell-based diabetes
 therapy. Even if successful, this approach poses a problem of scarce tissue supply. Xenotransplantation can be the answer
 to this limited donor availability and, among possible candidate tissues for xenotransplantation, porcine islets are the closest
 to a future clinical application. Xenotransplantation, with pigs as donors, offers the possibility of using healthy, living,
 and genetically modified islets from pathogen-free animals available in unlimited number of islets. Several studies in the
 pig-to-nonhuman primate model...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5098414</comments>
            <pubDate>Mon, 01 Aug 2011 05:32:19 +0100</pubDate>
            <guid isPermaLink="false">5098414</guid>        </item>
        <item>
            <title>Noninvasive Imaging Techniques in Islet Transplantation</title>
            <link>http://www.medworm.com/index.php?rid=5089010&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb76618176148k150%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Since the Edmonton trials, insulin independence can reproducibly be achieved after islet transplantation. However, a majority
 of patients resume insulin treatment in the first 5&amp;nbsp;years after transplantation. Several mechanisms have been proposed but
 are difficult to pinpoint in one particular patient. Current tools for the metabolic monitoring of islet grafts indicate islet
 dysfunction when it is too late to take action. Noninvasive imaging of transplanted islets could be used to study β-cell mass
 and β-cell function just after infusion, during vascularization or autoimmune and alloimmune attacks. This review will focus
 on the most recent advances in various imaging techniques (bioluminescence imaging, fluorescence optical imaging, MRI, and
 positron emission...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5089010</comments>
            <pubDate>Thu, 28 Jul 2011 15:53:22 +0100</pubDate>
            <guid isPermaLink="false">5089010</guid>        </item>
        <item>
            <title>Potential Pathways to Restore β-Cell Mass: Pluripotent Stem Cells, Reprogramming, and Endogenous Regeneration</title>
            <link>http://www.medworm.com/index.php?rid=5089011&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft366258l40u43101%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Currently available β-cell replacement therapies for patients with diabetes, including islet and pancreas transplantation,
 are largely successful in restoring normal glucose metabolism, but the scarcity of organ donors restricts their more widespread
 use. To solve this supply problem, several different strategies for achieving β-cell mass restoration are being pursued. These
 include the generation of β cells from stem cells and their subsequent transplantation, or regeneration-type approaches, such
 as stimulating endogenous regenerative mechanisms or inducing reprogramming of non-β cells into β cells. Because these strategies
 would ultimately generate allogeneic or syngeneic β cells in humans, the control of alloimmunity and/or autoimmunity in addition
 to re...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5089011</comments>
            <pubDate>Thu, 28 Jul 2011 15:53:21 +0100</pubDate>
            <guid isPermaLink="false">5089011</guid>        </item>
        <item>
            <title>The Past, Present, and Future of Genetic Associations in Type 1 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5080504&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx606534x8110g188%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Type 1 diabetes mellitus (T1DM) is an autoimmune disease affecting approximately one in 300 individuals in the United States.
 The majority of genetic research to date has focused on the heritability that predisposes to islet autoimmunity and T1DM.
 The evidence so far points to T1DM being a polygenic, common, complex disease with major susceptibility lying in the major
 histocompatibility complex (MHC) on chromosome 6 with other smaller effects seen in loci outside of the MHC. With recent advances
 in technology, novel means of exploring the human genome have given way to new information in the development of T1DM. The
 newest technologies, namely high-throughput polymorphism typing and sequencing, have led to a paradigm shift in studying common
 diseases such as T1DM....</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5080504</comments>
            <pubDate>Tue, 26 Jul 2011 15:48:23 +0100</pubDate>
            <guid isPermaLink="false">5080504</guid>        </item>
        <item>
            <title>Alternative Transplantation Sites for Pancreatic Islet Grafts</title>
            <link>http://www.medworm.com/index.php?rid=5070469&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw1538895r6707140%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The liver is the current site of choice for pancreatic islet transplantation, even though it is far from being an ideal site
 because of immunologic, anatomic, and physiologic factors leading to a significant early graft loss. A huge amount of alternative
 sites have been used for islet transplantation in experimental animal models to provide improved engraftment and long-term
 survival minimizing surgical complications. The pancreas, gastric submucosa, genitourinary tract, muscle, omentum, bone marrow,
 kidney capsule, peritoneum, anterior eye chamber, testis, and thymus have been explored. Site-specific differences exist in
 term of islet engraftment, but few alternative sites have potential clinical translation and generally the evidence of a post-transplant
 islet f...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5070469</comments>
            <pubDate>Mon, 25 Jul 2011 15:47:42 +0100</pubDate>
            <guid isPermaLink="false">5070469</guid>        </item>
        <item>
            <title>Blockade of Leukocyte Function Antigen-1 (LFA-1) in Clinical Islet Transplantation</title>
            <link>http://www.medworm.com/index.php?rid=5040522&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr1303t034046j225%2F</link>
            <description>Content Type Journal ArticlePages 1-8DOI 10.1007/s11892-011-0214-yAuthors
		Carmen Fotino, Diabetes Research Institute, University of Miami, 1450 NW 10th Avenue (R134), Miami, FL 33136, USAAntonello Pileggi, Diabetes Research Institute, University of Miami, 1450 NW 10th Avenue (R134), Miami, FL 33136, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5040522</comments>
            <pubDate>Thu, 14 Jul 2011 05:55:15 +0100</pubDate>
            <guid isPermaLink="false">5040522</guid>        </item>
        <item>
            <title>Impact of Islet Transplantation on Diabetes Complications and Quality of Life</title>
            <link>http://www.medworm.com/index.php?rid=5031062&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu44908501u52v175%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Insulin represents a life-saving therapy for patients with type 1 diabetes but, despite appropriate treatment, it prevents
 only partially long-term diabetic complications, while generating fatal hypoglycemic episodes. Islet transplantation gained
 attention because of its safety, effectiveness, and minimal invasiveness; however it remains a procedure reserved for a selected
 group of patients. The introduction of the Edmonton Protocol in 2000, based on a newly designed steroid-free immunosuppressive
 protocol, revamped the course of islet transplantation. The main goal of islet transplantation remains insulin independence,
 although the effect of islet transplantation can be more comprehensively evaluated in terms of frequency of hypoglycemic episodes
 and impact on di...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5031062</comments>
            <pubDate>Tue, 12 Jul 2011 06:00:50 +0100</pubDate>
            <guid isPermaLink="false">5031062</guid>        </item>
        <item>
            <title>The Use of Biomaterials in Islet Transplantation</title>
            <link>http://www.medworm.com/index.php?rid=5031063&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft23427115t04717x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pancreatic islet transplantation is a therapeutic option to replace destroyed β cells in autoimmune diabetes. Islets are transplanted
 into the liver via the portal vein; however, inflammation, the required immunosuppression, and lack of vasculature decrease
 early islet viability and function. Therefore, the use of accessory therapy and biomaterials to protect islets and improve
 islet function has definite therapeutic potential. Here we review the application of niche accessory cells and factors, as
 well as the use of biomaterials as carriers or capsules, for pancreatic islet transplantation.
 
 
	Content Type Journal ArticlePages 1-11DOI 10.1007/s11892-011-0210-2Authors
		Danielle J. Borg, Preclinical Approaches to Stem Cell Therapy/Diabetes, Technische Universitä...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5031063</comments>
            <pubDate>Tue, 12 Jul 2011 06:00:49 +0100</pubDate>
            <guid isPermaLink="false">5031063</guid>        </item>
        <item>
            <title>Pathogenic and Regulatory T Cells in Type 1 Diabetes: Losing Self-Control, Restoring It, and How to Take the Temperature</title>
            <link>http://www.medworm.com/index.php?rid=5010409&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F57613102n4167710%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The central role of T cells in type 1 diabetes pathogenesis is well established, but these cells continue to pose numerous
 challenges in understanding their dynamics and in following their modifications. Important progress has been recently made
 in pinpointing some novel antigens targeted by pathogenic T cells and the epitope sequences recognized. Studies on the interplay
 between effector T cells, their regulatory counterparts, and cells of the innate immune system have unraveled novel pathways
 and may inspire new therapeutic approaches. At the same time, the appreciation of the plasticity of regulatory T cells has
 raised important caveats on their use for cell-based therapies. Continuous development of T-cell assays exploring both pathogenic
 and regulatory player...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5010409</comments>
            <pubDate>Wed, 06 Jul 2011 05:48:52 +0100</pubDate>
            <guid isPermaLink="false">5010409</guid>        </item>
        <item>
            <title>Psychological Impact of Screening and Prediction in Type 1 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=4986755&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg7p7pj064v725645%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Screening programs designed to identify persons at risk for type 1 diabetes via genetic and antibody testing are controversial
 because they typically target children, provide only a crude estimate of type 1 diabetes risk, and offer no means of preventing
 the disease. For this reason, genetic and antibody testing for type 1 diabetes risk is usually limited to carefully conducted
 research studies. The psychological impact of such screening programs include cognitive, emotional, and behavioral sequelae;
 the available literature has focused primarily on parents, and usually mothers, since the target of screening is usually infants
 or young children. Diabetes risk is a difficult construct to effectively communicate. Many individuals fail to accurately
 understand risk; ...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4986755</comments>
            <pubDate>Mon, 27 Jun 2011 17:51:29 +0100</pubDate>
            <guid isPermaLink="false">4986755</guid>        </item>
        <item>
            <title>Experimental Approaches for High-Resolution In Vivo Imaging of Islet of Langerhans Biology</title>
            <link>http://www.medworm.com/index.php?rid=4970951&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F63603qpm43m6t530%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Under physiological conditions and in the pathogenesis of diabetes mellitus systemic influences play a substantial role for
 function and survival of cells of the islet of Langerhans. Therefore, in vivo studies to understand islet biology are indispensible
 and imaging techniques are increasingly used for this purpose. Among the diverse imaging modalities currently only laser scanning
 microscopy (LSM) allows resolution and visualization of individual cells and cellular processes. To overcome limited tissue
 penetration and working distance of LSM and enable in vivo investigations of islet cell physiology, various experimental approaches
 have been developed. Especially, the recently developed imaging platforms have significantly improved the possibility to study
 islet...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4970951</comments>
            <pubDate>Thu, 23 Jun 2011 16:22:45 +0100</pubDate>
            <guid isPermaLink="false">4970951</guid>        </item>
        <item>
            <title>Central Nervous System Involvement in Diabetic Neuropathy</title>
            <link>http://www.medworm.com/index.php?rid=4938329&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3r872n2673602578%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Diabetic neuropathy is a chronic and often disabling condition that affects a significant number of individuals with diabetes.
 Long considered a disease of the peripheral nervous system, there is now increasing evidence of central nervous system involvement.
 Recent advances in neuroimaging methods detailed in this review have led to a better understanding and refinement of how diabetic
 neuropathy affects the central nervous system. Recognition that diabetic neuropathy is, in part, a disease that affects the
 whole nervous system is resulting in a critical rethinking of this disorder, opening a new direction for further research.
 
 
	Content Type Journal ArticlePages 1-13DOI 10.1007/s11892-011-0205-zAuthors
		Dinesh Selvarajah, Diabetes Research Unit, Sheffield Teach...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4938329</comments>
            <pubDate>Mon, 13 Jun 2011 05:34:57 +0100</pubDate>
            <guid isPermaLink="false">4938329</guid>        </item>
        <item>
            <title>Recurrence of Autoimmunity Following Pancreas Transplantation</title>
            <link>http://www.medworm.com/index.php?rid=4938330&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh2817w3r6vm787q2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pancreas transplantation is a therapeutic option for patients with type 1 diabetes. Advances in immunosuppression have reduced
 immunologic failures, and these are usually categorized as chronic rejection. Yet studies in our cohort of pancreas transplant
 recipients identified several patients in whom chronic islet autoimmunity led to recurrent diabetes, despite immunosuppression
 that prevented rejection. Recurrent diabetes in our cohort is as frequent as chronic rejection, and thus is a significant
 cause of immunologic graft failure. Our studies demonstrated islet autoimmunity by the presence of autoantibodies and autoreactive
 T cells, which mediated ß-cell destruction in a transplantation model. Biopsy of the transplanted pancreas revealed variable
 degrees of ß-...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4938330</comments>
            <pubDate>Fri, 10 Jun 2011 06:32:26 +0100</pubDate>
            <guid isPermaLink="false">4938330</guid>        </item>
        <item>
            <title>Cell-Based Therapies for Diabetic Retinopathy</title>
            <link>http://www.medworm.com/index.php?rid=4904617&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F858256w4222254x1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Autologous endothelial progenitor cell (EPC) populations represent a novel treatment for therapeutic revascularization and
 vascular repair for diabetic patients with complications including diabetic retinopathy. Current therapies are applicable
 to late-stage disease and carry significant side effects, whereas cell-based therapy may provide an alternative by repairing
 areas of vasodegeneration and reversing ischemia. However, EPCs from diabetic patients with vascular complications are dysfunctional.
 Moreover, the diabetic environment poses its own challenges and complicates the use of autologous EPCs. Before EPCs become
 the ideal “cell therapy,” the optimal EPC must be determined, any functional dysfunction must be corrected prior to use, and
 the diabetic milie...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4904617</comments>
            <pubDate>Tue, 24 May 2011 16:03:40 +0100</pubDate>
            <guid isPermaLink="false">4904617</guid>        </item>
        <item>
            <title>Microvascular Modifications in Diabetic Retinopathy</title>
            <link>http://www.medworm.com/index.php?rid=4904616&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg2641506n1w56w83%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Patients struggling with diabetes are at elevated risks for several sight-threatening diseases, including proliferative diabetic
 retinopathy (DR). DR manifests in two stages: first, the retinal microvasculature is compromised and capillary degeneration
 occurs; subsequently, an over-compensatory angiogenic response is initiated. Early changes in the retinal microcirculation
 include disruptions in blood flow, thickening of basement membrane, eventual loss of mural cells, and the genesis of acellular
 capillaries. Endothelial apoptosis and capillary dropout lead to a hypoxic inner retina, alterations in growth factors, and
 upregulation of inflammatory mediators. With disease progression, pathologic angiogenesis generates abnormal preretinal microvessels.
 Current thera...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4904616</comments>
            <pubDate>Tue, 24 May 2011 16:03:40 +0100</pubDate>
            <guid isPermaLink="false">4904616</guid>        </item>
        <item>
            <title>Painful Diabetic Neuropathy is More than Pain Alone: Examining the Role of Anxiety and Depression as Mediators and Complicators</title>
            <link>http://www.medworm.com/index.php?rid=4904618&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy3626v8725081257%2F</link>
            <description>This article reviews the high rate of comorbidity between DPNP and depression/anxiety with a focus on why this pattern
 of comorbidity exists and what can be done about it. To accomplish this, the many physiologic similarities between neuropathic
 pain and depression/anxiety are reviewed as a basis for better understanding how, and why, optimal treatment strategies use
 behavioral and pharmacologic modalities known to improve both physical pain and symptoms of depression and anxiety. We conclude
 by highlighting that screening, diagnosing, and optimally treating comorbid depression/anxiety not only improves quality of
 life, these but also positively impacts DPNP pain.
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s11892-011-0202-2Authors
		Rakesh Jain, Department of Psychiatry, T...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4904618</comments>
            <pubDate>Tue, 24 May 2011 16:03:39 +0100</pubDate>
            <guid isPermaLink="false">4904618</guid>        </item>
        <item>
            <title>Imaging of Diabetic Retinopathy and Diabetic Macular Edema</title>
            <link>http://www.medworm.com/index.php?rid=4904619&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh73w265551966682%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Imaging of the retinal complications of diabetes mellitus is rapidly changing from the emergence of new technology such as
 optical coherence tomography. In particular, the characterization of diabetic macular edema is much easier for the clinician
 and there are new, more sensitive clinical research end points. However, our understanding of structure-functional relationships
 remains suboptimal and the classification of macular edema by optical coherence tomography continues to evolve. The classification
 of diabetic retinopathy severity continues to rely upon fundus photography, although the transition from film to digital photography
 presents both challenges and advantages.
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s11892-011-0203-1Authors
		Ronald P. Da...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4904619</comments>
            <pubDate>Mon, 23 May 2011 16:59:11 +0100</pubDate>
            <guid isPermaLink="false">4904619</guid>        </item>
        <item>
            <title>Intravitreal Anti-VEGF Therapy with Prompt or Deferred Laser Compared with Steroid with Prompt Laser and Prompt Laser Alone for Treatment of Diabetic Macular Edema</title>
            <link>http://www.medworm.com/index.php?rid=4854712&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv227124x14083l36%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s11892-011-0201-3Authors
		Jennifer K. Sun, Beetham Eye Institute and Eye Research Section, Joslin Diabetes Center; Department of Ophthalmology, Harvard Medical School, Boston, MA, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4854712</comments>
            <pubDate>Fri, 20 May 2011 16:10:35 +0100</pubDate>
            <guid isPermaLink="false">4854712</guid>        </item>
        <item>
            <title>Does Therapy Targeting Normal SBP of Less than 120 mm Hg Reduce Major CV Events in T2DM Patients?</title>
            <link>http://www.medworm.com/index.php?rid=4854713&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4895681j66623xhw%2F</link>
            <description>Does Therapy Targeting Normal SBP of Less than 120 mm Hg Reduce Major CV Events in T2DM Patients?
	Content Type Journal ArticlePages 1-3DOI 10.1007/s11892-011-0200-4Authors
		Bijan Roshan, Joslin Diabetes Center, 1 Joslin Place, Boston, MA 02215, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4854713</comments>
            <pubDate>Fri, 20 May 2011 16:10:34 +0100</pubDate>
            <guid isPermaLink="false">4854713</guid>        </item>
        <item>
            <title>Is Duloxetine More Effective than Amitriptyline for Painful Diabetic Neuropathy?</title>
            <link>http://www.medworm.com/index.php?rid=4854714&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3j135072133w6727%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s11892-011-0199-6Authors
		Andrew J. M. Boulton, Manchester Diabetes Centre, 193 Hathersage Road, Manchester, M13 0JE UK
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4854714</comments>
            <pubDate>Thu, 19 May 2011 16:12:43 +0100</pubDate>
            <guid isPermaLink="false">4854714</guid>        </item>
        <item>
            <title>AGEs, RAGE, and Diabetic Retinopathy</title>
            <link>http://www.medworm.com/index.php?rid=4854715&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5w6m4n180171m347%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Diabetic retinopathy is a major diabetic complication with a highly complex etiology. Although there are many pathways involved,
 it has become established that chronic exposure of the retina to hyperglycemia gives rise to accumulation of advanced glycation
 end products (AGEs) that play an important role in retinopathy. In addition, the receptor for AGEs (RAGE) is ubiquitously
 expressed in various retinal cells and is upregulated in the retinas of diabetic patients, resulting in activation of pro-oxidant
 and proinflammatory signaling pathways. This AGE-RAGE axis appears to play a central role in the sustained inflammation, neurodegeneration,
 and retinal microvascular dysfunction occurring during diabetic retinopathy. The nature of AGE formation and RAGE signaling
 b...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4854715</comments>
            <pubDate>Wed, 18 May 2011 06:18:38 +0100</pubDate>
            <guid isPermaLink="false">4854715</guid>        </item>
        <item>
            <title>A Review of the Eurodiale Studies: What Lessons for Diabetic Foot Care?</title>
            <link>http://www.medworm.com/index.php?rid=4832340&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8136ur543516244t%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The prevalence of diabetes has been increasing at an alarming rate worldwide. Treatment of diabetes-related complications
 adds a huge financial burden on our health services, made worse in the current financial climate. The Eurodiale (European
 Study Group on Diabetes and the Lower Extremity) study was a prospective observational study conducted in 14 European centers
 in 2003 to 2004 and included data on characteristics of diabetic patients with foot ulcers, diagnostic and management procedures,
 health care organization, quality of life, and resource use. This was the first large multicenter study, included 1232 patients,
 and used an integrated approach for a multiorgan disease. The study has provided new insights into the intricacies involved
 in managing diabetic ...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4832340</comments>
            <pubDate>Sat, 14 May 2011 15:51:36 +0100</pubDate>
            <guid isPermaLink="false">4832340</guid>        </item>
        <item>
            <title>Oxidative Stress and Diabetic Kidney Disease</title>
            <link>http://www.medworm.com/index.php?rid=4822513&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb14715n25h651043%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The number of people with diabetic kidney disease continues to increase worldwide despite current treatments. Of the pathophysiologic
 mechanisms that have been identified in the development and progression of diabetic nephropathy, oxidative stress (more accurately
 described as increased levels of reactive oxygen species; ROS) is of major importance. The increase in ROS is due to both
 increased production and to decreased and/or inadequate antioxidant function. To date, human clinical trials with antioxidants
 have not been shown to be effective. This is likely due, at least in part, to the lack of specificity of current agents. Recent
 research has determined both major sources of high glucose–induced cellular ROS production as well as high glucose–induced
 chang...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4822513</comments>
            <pubDate>Tue, 10 May 2011 05:57:06 +0100</pubDate>
            <guid isPermaLink="false">4822513</guid>        </item>
        <item>
            <title>What is the Role of Hyperbaric Oxygen in the Management of Diabetic Foot Disease?</title>
            <link>http://www.medworm.com/index.php?rid=4783167&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F482gn04m5q5298w2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Systemic hyperbaric oxygen (HBO) is accomplished when a patient is breathing 100% oxygen in an environment with increased
 barometric pressure. A typical HBO treatment protocol of diabetic foot ulcer involves 20 to 40 sessions. Treatment is usually
 given as daily 90- to 120-minute HBO sessions at pressures between 2.0 and 2.5 absolute atmospheres. The wide use of HBO as
 treatment of diabetic foot ulcers over the past decades has been founded on weak scientific ground (ie, few and small prospective
 studies with methodologic limitations on top of case series). However, the consistency in positive outcome in these trials
 evaluating HBO on ulcer healing is noteworthy because these findings are in concert with data from in vitro and physiologic
 studies supporting the th...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783167</comments>
            <pubDate>Mon, 02 May 2011 05:43:12 +0100</pubDate>
            <guid isPermaLink="false">4783167</guid>        </item>
        <item>
            <title>The Goal of Blood Pressure Control for Prevention of Early Diabetic Microvascular Complications</title>
            <link>http://www.medworm.com/index.php?rid=4783168&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx3674455857l6017%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Lowering blood pressure may confer a benefit to diabetic microvascular complications comparable with glycemic control. Hypertension
 is causally related to kidney outcomes and is a risk factor for the development of diabetic retinopathy. The prevalence of
 hypertension increases as kidney disease progresses, so that it coexists with diabetes in up to 80% of those with overt nephropathy.
 A significant number of patients have hypertension or rising blood pressures in earlier stages, or even before microvascular
 complications appear. Because microalbuminuria markedly increases the risk of overt nephropathy as well as of cardiovascular
 complications, primary prevention (i.e., preventing or delaying the onset of microalbuminuria) continues to be explored, predominantly
 t...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783168</comments>
            <pubDate>Wed, 27 Apr 2011 08:45:17 +0100</pubDate>
            <guid isPermaLink="false">4783168</guid>        </item>
        <item>
            <title>Screening for the High-risk Foot of Ulceration: Tests of Somatic and Autonomic Nerve Function</title>
            <link>http://www.medworm.com/index.php?rid=4726080&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd3mw10730858l252%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Diabetic foot ulcers affect almost 5% of the patients with diabetes and carry a huge physical, emotional, and financial burden.
 Almost 80% of amputations in patients with diabetes are preceded by a foot ulcer. The need for simple screening methods for
 prevention of foot ulcers and amputations is indisputable. Simple tests such as monofilament, tuning fork, vibration perception
 threshold determination, ankle reflexes, and pinprick sensation alone or in combination have been studied prospectively and
 can be used for identification of patients at risk. Newer tests examining sudomotor dysfunction and skin dryness have been
 introduced in recent years. In cross-sectional studies sudomotor dysfunction assessed by either sympathetic skin response
 or NEUROPAD™ (Miro Verb...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4726080</comments>
            <pubDate>Thu, 14 Apr 2011 16:59:52 +0100</pubDate>
            <guid isPermaLink="false">4726080</guid>        </item>
        <item>
            <title>Perivascular Adipose Tissue and Its Role in Type 2 Diabetes and Cardiovascular Disease</title>
            <link>http://www.medworm.com/index.php?rid=4687008&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb25vg20m17148054%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Obesity is associated with insulin resistance, hypertension, and cardiovascular disease, but the mechanisms underlying these
 associations are incompletely understood. Microvascular dysfunction may play an important role in the pathogenesis of both
 insulin resistance and hypertension in obesity. Adipose tissue-derived substances (adipokines) and especially inflammatory
 products of adipose tissue control insulin sensitivity and vascular function. In the past years, adipose tissue associated
 with the vasculature, or perivascular adipose tissue (PAT), has been shown to produce a variety of adipokines that contribute
 to regulation of vascular tone and local inflammation. This review describes our current understanding of the mechanisms linking
 perivascular adipose tiss...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4687008</comments>
            <pubDate>Mon, 04 Apr 2011 05:39:22 +0100</pubDate>
            <guid isPermaLink="false">4687008</guid>        </item>
        <item>
            <title>Gut Microbiota and the Pathogenesis of Insulin Resistance</title>
            <link>http://www.medworm.com/index.php?rid=4645057&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj5953t706h4r4482%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Several reviews recently explored how the gut microbiota was able to control host energy metabolism, and thereby the development
 of adiposity. In this review, we focused on the state of the art that supports a link between the gut microbiota composition
 and activity, and the management of glycemia associated with overweight and diabetes. Several microbial-derived compounds
 are related to disturbances of glucose homeostasis including the gram-negative–derived lipopolysaccharides. Some nutrients
 with prebiotic properties, which escape the digestion in the upper part of the gut, modify the composition of the gut microbiota
 in favor of bacteria that could play a beneficial role on glucose homeostasis, namely by modulating the endocrine function
 of the gut, and by re...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4645057</comments>
            <pubDate>Wed, 23 Mar 2011 16:56:06 +0100</pubDate>
            <guid isPermaLink="false">4645057</guid>        </item>
        <item>
            <title>Bile Acid Metabolism and the Pathogenesis of Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=4645056&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft69876763q621t36%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Type 2 diabetes (T2D) is a growing health problem worldwide, but the currently available strategies for therapy and prevention
 are insufficient. Recent observations indicate that bile acid homeostasis is altered in T2D. Bile acids are metabolic regulators
 that act as signaling molecules through receptor-dependent and -independent pathways. The most prominent signaling molecules
 mediating bile acid signaling are the nuclear receptor farnesoid X receptor (FXR) and the membrane receptor TGR5. Both are
 implicated in the regulation of lipid, glucose, and energy metabolism. Dysregulation of these pathways might contribute to
 the development of T2D and associated complications. Interestingly, data from studies with bile acids or bile acid sequestrants
 indicate that the m...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4645056</comments>
            <pubDate>Wed, 23 Mar 2011 16:56:06 +0100</pubDate>
            <guid isPermaLink="false">4645056</guid>        </item>
        <item>
            <title>Why Does NAFLD Predict Type 2 Diabetes?</title>
            <link>http://www.medworm.com/index.php?rid=4645058&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F214x04j02802j932%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Based on the “lipotoxic” hypothesis, the free fatty acid flux from the excessive amount of adipose tissue toward the peripheral
 tissues would induce the development of insulin resistance especially when the triglyceride storage or the concentration of
 intermediate fat metabolites (diacylglycerides, ceramides) within the cytoplasm of these cells become excessive. Nonalcoholic
 fatty liver disease (NAFLD) includes a wide spectrum of liver damage, ranging from simple steatosis to steatohepatitis and
 advanced fibrosis. NAFLD is associated with general and intra-abdominal obesity and with a reduced ability of insulin to stimulate
 metabolic pathways in the liver itself and in other tissues. There are animal models and models in human diseases sustaining
 the hypothesi...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4645058</comments>
            <pubDate>Wed, 23 Mar 2011 16:56:03 +0100</pubDate>
            <guid isPermaLink="false">4645058</guid>        </item>
        <item>
            <title>Peripheral Arterial Disease in Diabetes: Is There a Role for Genetics?</title>
            <link>http://www.medworm.com/index.php?rid=4632600&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F25840152v58n3136%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Atherosclerotic occlusion of vessels outside of the heart is commonly referred to as peripheral arterial disease (PAD). The
 lower extremity is the most common site of PAD and its development is associated with the same risk factors involved in general
 atherosclerosis. However, there is emerging evidence that other risk factors may play a key role in the development of PAD.
 Over the past decade polymorphism in a number of genes has been shown to contribute to the risk of developing PAD. These genes
 can be classified into proartherosclerosis or proatherothrombosis based on the known gene function. Moreover, they can be
 categorized as “novel” polymorphism when the function of the genes is not known or when the specific gene within an associated
 genetic locus is n...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4632600</comments>
            <pubDate>Mon, 21 Mar 2011 18:56:51 +0100</pubDate>
            <guid isPermaLink="false">4632600</guid>        </item>
        <item>
            <title>Adipose Tissue Dysfunction in Polycystic Ovary Syndrome</title>
            <link>http://www.medworm.com/index.php?rid=4623360&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh1p4j47775w08035%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder among premenopausal women. In addition to infertility,
 PCOS is associated with insulin resistance, features of the metabolic syndrome, and an increased risk for diabetes. Similar
 to individuals with metabolic syndrome, many women with PCOS manifest abdominal obesity, suggesting adipose tissue dysfunction.
 The adipose tissue of women with PCOS is characterized by hypertrophic adipocytes and impairments in lipolysis and insulin
 action. The expression and secretion of a wide variety of adipokines implicated in insulin resistance, including adiponectin
 and others, are also altered in PCOS. Collectively, the available data indicate that adipose tissue dysfunction plays a central
 role in the m...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4623360</comments>
            <pubDate>Sat, 19 Mar 2011 02:52:26 +0100</pubDate>
            <guid isPermaLink="false">4623360</guid>        </item>
        <item>
            <title>Erratum to: Inpatient Enteral and Parental Nutrition for Patients with Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=4581913&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F91hq240316609410%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s11892-011-0185-zAuthors
		Michael A. Via, Division of Endocrinology and Metabolism, Beth Israel Medical Center, Albert Einstein College of Medicine, 55 East 34th Street, New York, NY 10016, USAJeffrey I. Mechanick, Metabolic Support, Division of Endocrinology, Diabetes, and Bone Disease, Mount Sinai School of Medicine, New York, NY USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4581913</comments>
            <pubDate>Fri, 11 Mar 2011 18:05:31 +0100</pubDate>
            <guid isPermaLink="false">4581913</guid>        </item>
        <item>
            <title>Human Vascular Endothelial Cells: A Model System for Studying Vascular Inflammation in Diabetes and Atherosclerosis</title>
            <link>http://www.medworm.com/index.php?rid=4513688&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm1723w6366854678%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The vascular endothelium is the inner lining of blood vessels serving as autocrine and paracrine organ that regulates vascular
 wall function. Endothelial dysfunction is recognized as initial step in the atherosclerotic process and is well advanced in
 diabetes, even before the manifestation of end-organ damage. Strategies capable of assessing changes in vascular endothelium
 at the preclinical stage hold potential to refine cardiovascular risk. In vitro cell culture is useful in understanding the interaction of endothelial cells with various mediators; however, it is often
 criticized due to the uncertain relevance of results to humans. Although circulating endothelial cells, endothelial microparticles,
 and progenitor cells opened the way for ex vivo studies, a recent...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4513688</comments>
            <pubDate>Mon, 21 Feb 2011 06:36:14 +0100</pubDate>
            <guid isPermaLink="false">4513688</guid>        </item>
        <item>
            <title>Does the Metabolic Syndrome Carry Additional Risk for Myocardial Infarction?</title>
            <link>http://www.medworm.com/index.php?rid=4513690&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff801016x74025446%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s11892-011-0181-3Authors
		Allison Schneider, Diabetes and Metabolism Translational Medicine Unit, Division of Endocrinology, Diabetes and Metabolism, University of Vermont College of Medicine, 208 Park Street, Colchester Research Facility, 110C, Colchester, VT 05466, USARichard E. Pratley, Diabetes and Metabolism Translational Medicine Unit, Division of Endocrinology, Diabetes and Metabolism, University of Vermont College of Medicine, 208 Park Street, Colchester Research Facility, 110C, Colchester, VT 05466, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4513690</comments>
            <pubDate>Sat, 19 Feb 2011 07:07:06 +0100</pubDate>
            <guid isPermaLink="false">4513690</guid>        </item>
        <item>
            <title>Alternative and Complementary Treatments for Metabolic Syndrome</title>
            <link>http://www.medworm.com/index.php?rid=4513689&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy712636481714503%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Metabolic syndrome is defined by a cluster of cardiovascular disease risk factors that are associated with insulin resistance.
 In recent years, a number of innovative nutritional strategies have been proposed as safe alternative treatments to reduce
 the morbidity as well as the cost of treating metabolic syndrome. Of these, dietary supplementation with chromium picolinate
 or cinnamon extract has been studied most extensively. These interventions may attenuate insulin resistance and reduce the
 cardiovascular risk factors that together comprise the metabolic syndrome. However, more clinical trials are needed to determine
 the dose and duration of such treatments to make specific recommendations for populations with metabolic syndrome.
 
 
	Content Type Journal Article...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4513689</comments>
            <pubDate>Sat, 19 Feb 2011 07:07:06 +0100</pubDate>
            <guid isPermaLink="false">4513689</guid>        </item>
        <item>
            <title>Cardiovascular Function/Dysfunction in Adolescents with Type 1 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=4513691&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx26642788271n552%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Type 1 diabetes mellitus (T1D) is associated with an increased risk of cardiovascular disease (CVD) that begins in childhood.
 Youth with T1D develop concerning functional cardiac and vascular defects and evidence of early atherosclerosis, despite modern
 advancements in risk reduction and glycemic management. Such early defects predict poor long-term outcomes. Women with T1D
 also have higher CVD risk than expected for unexplained reasons. Insulin resistance (IR) is recently recognized as a prominent
 factor in T1D youth and adults, but with an atypical clinical phenotype. This IR may contribute to early cardiac and vascular
 dysfunction and long-term CVD in T1D. A better understanding of potential contributors to cardiovascular dysfunction in T1D
 youth such as IR and...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4513691</comments>
            <pubDate>Sat, 19 Feb 2011 07:07:05 +0100</pubDate>
            <guid isPermaLink="false">4513691</guid>        </item>
        <item>
            <title>Adipose Tissue Vascularization: Its Role in Chronic Inflammation</title>
            <link>http://www.medworm.com/index.php?rid=4496142&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc642810820336311%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In obesity, the vascular complication is a result of insulin resistance, such as decreased capillary recruitment in skeletal
 muscle from endothelial insulin resistance. Recent progress in the study of obesity-associated inflammation suggests that
 vasculature dysfunction occurs in adipose tissue before insulin resistance. In obesity, capillary density and function fail
 to meet the demand of adipose tissue growth. The failure leads to microcirculation dysfunction from an impaired blood perfusion,
 which results in a local hypoxia response in adipose tissue. The hypoxia response in adipocytes and macrophages is a new cellular
 basis for the chronic inflammation. The obesity-associated inflammation has both positive and negative effects in the body.
 At the early stage, ...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4496142</comments>
            <pubDate>Wed, 16 Feb 2011 07:00:04 +0100</pubDate>
            <guid isPermaLink="false">4496142</guid>        </item>
        <item>
            <title>Nutritional Supplements and Their Effect on Glucose Control</title>
            <link>http://www.medworm.com/index.php?rid=4461135&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg74x21k7plm2m064%2F</link>
            <description>The objective of this review was to search the scientific literature for advances in the treatment
 and prevention of type 2 diabetes with nutritional supplements. Twelve databases were searched with a focus on extracting
 studies published in the past 3&amp;nbsp;years. The following nutritional supplements were identified as potentially beneficial for
 type 2 diabetes treatment or prevention: vitamins C and E, α-lipoic acid, melatonin, red mold, emodin from Aloe vera and Rheum officinale, astragalus, and cassia cinnamon. Beta-carotene was shown to be ineffective in the prevention of type 2 diabetes. Ranging
 from preclinical to clinical, there is evidence that nutritional supplements may be beneficial in the treatment or prevention
 of type 2 diabetes. Health providers should investigate dru...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4461135</comments>
            <pubDate>Mon, 07 Feb 2011 06:40:20 +0100</pubDate>
            <guid isPermaLink="false">4461135</guid>        </item>
        <item>
            <title>Nutrition Therapy and the Management of Obesity and Diabetes: An Update</title>
            <link>http://www.medworm.com/index.php?rid=4378789&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk1185668v7387347%2F</link>
            <description>This article will summarize
 research conducted over the past 2&amp;nbsp;years examining medical nutrition therapy for diabetes and obesity. It will also describe
 the unique challenges that come with treating this patient population.
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s11892-011-0176-0Authors
		Gillian G. Arathuzik, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USAAnn E. Goebel-Fabbri, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4378789</comments>
            <pubDate>Mon, 17 Jan 2011 20:40:26 +0100</pubDate>
            <guid isPermaLink="false">4378789</guid>        </item>
        <item>
            <title>Are Sulfonylureas Less Desirable Than DPP-4 Inhibitors as Add-on to Metformin in the Treatment of Type 2 Diabetes?</title>
            <link>http://www.medworm.com/index.php?rid=4378790&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbv1xj66m20441q83%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Sulfonylureas (SUs) are commonly used as add-on to metformin in treatment of type 2 diabetes in patients who are insufficiently
 controlled by metformin alone. They have good efficacy and have been shown to prevent microvascular complications. However,
 treatment with SUs is also associated with a high frequency of hypoglycemia, increased body weight, and a high risk of secondary
 failure. During recent years, dipeptidyl peptidase-4 (DPP-4) inhibitors have emerged as alternatives to SUs. They show similar
 efficacy as SUs but with lower risk of hypoglycemia, and reduction or no change in body weight, and if confirmed in humans,
 they may preserve islet function and thereby minimize the risk for secondary failure. Their limitation at present is the lack
 of long-term (&amp;g...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4378790</comments>
            <pubDate>Mon, 17 Jan 2011 20:40:25 +0100</pubDate>
            <guid isPermaLink="false">4378790</guid>        </item>
        <item>
            <title>Fad Diets in the Treatment of Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=4363456&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F106484225825h556%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Use of the term “fad diet” reflects the contentious nature of the debate in the treatment of diabetes and generally targets
 diets based on carbohydrate restriction, the major challenge to traditional dietary therapy. Although standard low-fat diets
 more accurately conform to the idea of a practice supported by social pressure rather than scientific data, it is suggested
 that we might want to give up altogether unscientific terms like “fad” and “healthy.” Far from faddish, diets based on carbohydrate
 restriction have been the historical treatment for diabetes and are still supported by basic biochemistry, and it is argued
 that they should be considered the “default” diet, the one to try first, in diseases of carbohydrate intolerance or insulin
 resis...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4363456</comments>
            <pubDate>Sat, 15 Jan 2011 00:57:12 +0100</pubDate>
            <guid isPermaLink="false">4363456</guid>        </item>
        <item>
            <title>Which Combination Therapy Is Superior at Reducing Cardiovascular Events in Diabetic Patients with Hypertension?</title>
            <link>http://www.medworm.com/index.php?rid=4345862&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy0603x861m243243%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s11892-011-0177-zAuthors
		Charles T. Upchurch, Division of Endocrinology, University of Virginia, 420 Ray C. Hunt Drive, Box 801390, Charlottesville, VA 22906, USAEugene J. Barrett, Endocrinology &amp; Metabolism, University of Virginia, 420 Ray C. Hunt Drive, Box 801390, Charlottesville, VA 22906, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4345862</comments>
            <pubDate>Tue, 11 Jan 2011 07:34:19 +0100</pubDate>
            <guid isPermaLink="false">4345862</guid>        </item>
        <item>
            <title>Nonsurgical Diabetes Weight Management: Be Prepared for Sustainable and Practical Interventions</title>
            <link>http://www.medworm.com/index.php?rid=4345864&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu371521j26635560%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s11892-010-0172-9Authors
		Osama Hamdy, Joslin Diabetes Center, One Joslin Place, Boston, MA 02481, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4345864</comments>
            <pubDate>Mon, 10 Jan 2011 15:54:22 +0100</pubDate>
            <guid isPermaLink="false">4345864</guid>        </item>
        <item>
            <title>Glycemic Index and Glycemic Load of Carbohydrates in the Diabetes Diet</title>
            <link>http://www.medworm.com/index.php?rid=4345863&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F420470478w053011%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Medical nutrition therapy is the first line of treatment for the prevention and management of type 2 diabetes and plays an
 essential part in the management of type 1 diabetes. Although traditionally advice was focused on carbohydrate quantification,
 it is now clear that both the amount and type of carbohydrate are important in predicting an individual’s glycemic response
 to a meal. Diets based on carbohydrate foods that are more slowly digested, absorbed, and metabolized (i.e., low glycemic
 index [GI] diets) have been associated with a reduced risk of type 2 diabetes and cardiovascular disease, whereas intervention
 studies have shown improvements in insulin sensitivity and glycated hemoglobin concentrations in people with diabetes following
 a low GI diet. Resear...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4345863</comments>
            <pubDate>Mon, 10 Jan 2011 15:54:22 +0100</pubDate>
            <guid isPermaLink="false">4345863</guid>        </item>
        <item>
            <title>What’s Wrong with Too Low? Is Hypoglycemia a Marker or a Cause of CVD and Mortality Risk?</title>
            <link>http://www.medworm.com/index.php?rid=4327602&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fwv7u40wkm73j2226%2F</link>
            <description>Content Type Journal ArticlePages 1-4DOI 10.1007/s11892-010-0174-7Authors
		Anthony L. McCall, Diabetes and Hormone Center of Excellence, University of Virginia Health System, Box 801407, 450 Ray C. Hunt Drive, Charlottesville, VA 22908, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4327602</comments>
            <pubDate>Fri, 07 Jan 2011 14:51:46 +0100</pubDate>
            <guid isPermaLink="false">4327602</guid>        </item>
        <item>
            <title>Should the Metabolic Syndrome Patient with Prediabetes Be Offered Pharmacotherapy?</title>
            <link>http://www.medworm.com/index.php?rid=4319372&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe55q6764r1156426%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Impaired fasting glucose and impaired glucose tolerance reflect perturbations in glucose metabolism and define a prediabetic
 state in which risk for type 2 diabetes mellitus (T2DM) is increased. There is overlap between prediabetes and the metabolic
 syndrome, which itself increases the risk for T2DM and cardiovascular disease. The utility of medical interventions to prevent
 progression to diabetes in prediabetic individuals, many of whom also manifest metabolic syndrome, has been examined in several
 large clinical trials. Intensive lifestyle intervention consistently results in drastic reductions in the incidence of T2DM
 and reversal of metabolic syndrome. Additionally, pharmacotherapies—including metformin, acarbose, thiazolidinediones, glucagon-like
 peptide 1 ...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4319372</comments>
            <pubDate>Tue, 04 Jan 2011 17:55:12 +0100</pubDate>
            <guid isPermaLink="false">4319372</guid>        </item>
        <item>
            <title>Protein Content in Diabetes Nutrition Plan</title>
            <link>http://www.medworm.com/index.php?rid=4319371&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn89833246183n237%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Medical nutrition therapy plays a major role in diabetes management. Macronutrient composition has been debated for a long
 time. However, there is increasing evidence that a modest increase in dietary protein intake above the current recommendation
 is a valid option toward better diabetes control, weight reduction, and improvement in blood pressure, lipid profile, and
 markers of inflammation. Increasing the absolute protein intake to 1.5–2&amp;nbsp;g/kg (or 20–30% of total caloric intake) during weight
 reduction has been suggested for overweight and obese patients with type 2 diabetes and normal kidney function. Increased
 protein intake does not increase plasma glucose, but increases the insulin response and results in a significant reduction
 in hemoglobin A1c. In...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4319371</comments>
            <pubDate>Tue, 04 Jan 2011 17:55:12 +0100</pubDate>
            <guid isPermaLink="false">4319371</guid>        </item>
        <item>
            <title>Origins of and Recognition of Micronutrient Deficiencies After Gastric Bypass Surgery</title>
            <link>http://www.medworm.com/index.php?rid=4289194&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F01t603j160704326%2F</link>
            <description>This article supports ongoing examination of nutritional complications after gastric bypass
 surgery and supports the notion that the daily doses of micronutrient supplements, such as vitamin D, may need to be revised.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0169-4Authors
		Bikram S. Bal, Section of Gastroenterology, Washington Hospital Center, Washington, DC 20010, USAFrederick C. Finelli, Department of Surgery, Washington Hospital Center, Washington, DC 20010, USATimothy R. Koch, Department of Medicine and Georgetown University School of Medicine, Washington Hospital Center, POB North, Suite 3400, 110 Irving Street, NW, Washington, DC 20010, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4289194</comments>
            <pubDate>Wed, 22 Dec 2010 20:23:52 +0100</pubDate>
            <guid isPermaLink="false">4289194</guid>        </item>
        <item>
            <title>Inpatient Enteral and Parental Nutrition for Patients with Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=4273090&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa84q16qu63t26n1w%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Both glycemic control and adequate nutrition support impact the clinical outcome of hospitalized patients. Providing nutrition
 to malnourished patients using the enteral or parenteral route may increase the risk of hyperglycemia, especially in patients
 with diabetes. Hyperglycemia can be managed through the use of enteral tube feeds with reduced carbohydrate content or limiting
 the carbohydrate concentration in parenteral formulas. Judicious use of insulin or other glucose-lowering medications synchronized
 with appropriate nutrition support allows for optimal inpatient glycemic control.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0168-5Authors
		Michael A. Via, Division of Endocrinology and Metabolism, Beth Israel Medical Center, Albert Einstein College ...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273090</comments>
            <pubDate>Fri, 17 Dec 2010 17:42:03 +0100</pubDate>
            <guid isPermaLink="false">4273090</guid>        </item>
        <item>
            <title>Extreme Insulin Resistance: Indications and Approaches to the Use of U-500 Insulin in Type 2 Diabetes Mellitus</title>
            <link>http://www.medworm.com/index.php?rid=4267883&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd854h2k568836022%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The use of U-500 insulin in the management of highly insulin resistant diabetic patients is growing. There are a number of
 reports that have noted the effects of U-500 insulin using multiple daily injections or continuous subcutaneous insulin infusion
 on hemoglobin A1c, weight, and total daily insulin dosage. The effect of U-500 insulin use on glycemic control, changes in body weight, total
 daily insulin dosage, incidence of hypoglycemia, and effect on lipid levels and blood pressure as well as patient satisfaction
 and quality of life will be reviewed. In addition, this article will delineate algorithms of U-500 use, compare multiple daily
 injections or continuous subcutaneous insulin infusion, and discuss U-500 insulin pharmacokinetics.
 
 
	Content Type Journal A...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4267883</comments>
            <pubDate>Wed, 15 Dec 2010 16:05:35 +0100</pubDate>
            <guid isPermaLink="false">4267883</guid>        </item>
        <item>
            <title>Resistant Hypertension and Sleep Apnea: Pathophysiologic Insights and Strategic Management</title>
            <link>http://www.medworm.com/index.php?rid=4198128&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F16685t347p474p17%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Resistant hypertension is common among adults with hypertension affecting up to 30% of patients. The treatment of resistant
 hypertension is important because suboptimal blood pressure control is the leading preventable cause of death worldwide. A
 frequent comorbid condition in patients with resistant hypertension is obstructive sleep apnea. The pathophysiology of sleep
 apnea–associated hypertension is characterized by sustained adrenergic activation and volume retention often posing treatment
 challenges in patients with resistant hypertension. This review will address some of the epidemiologic data associating apnea
 with the pathogenesis of resistant hypertension. Diagnosis and management of apnea and its associated hypertension will also
 be considered.
 
 
	Con...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4198128</comments>
            <pubDate>Mon, 22 Nov 2010 13:22:35 +0100</pubDate>
            <guid isPermaLink="false">4198128</guid>        </item>
        <item>
            <title>Update on the Prevention of Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=4187432&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff5000p564372372n%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Diabetes has emerged as the modern day epidemic that is currently affecting over 220 million people worldwide and claiming
 at least 1.1 million lives in 2005 alone. The rise in diabetes is largely attributed to the epidemic of obesity together with
 sedentary lifestyle as well as unhealthy dietary habits. Despite evidence that glycemic control as well as control of other
 cardiovascular disease (CVD) risk factors such as hypertension and dyslipidemia decreases morbidity and mortality in the diabetic
 population, control of glycemia and other CVD risk factors remains largely suboptimal making the concept of prevention of
 diabetes very appealing to control CVD risk, especially that such a risk is already increased in people in the prediabetic
 stage. Several large contr...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4187432</comments>
            <pubDate>Wed, 17 Nov 2010 20:58:24 +0100</pubDate>
            <guid isPermaLink="false">4187432</guid>        </item>
        <item>
            <title>Cardiovascular Disease in Chronic Kidney Disease: Data from the Kidney Early Evaluation Program (KEEP)</title>
            <link>http://www.medworm.com/index.php?rid=4176418&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl1ur68p16268148q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Diabetes mellitus (DM) and hypertension (HTN) are leading joint risk factors for both cardiovascular disease (CVD) and chronic
 kidney disease (CKD). In the nationwide KEEP (Kidney Early Evaluation Program) an estimated glomerular filtration rate less
 than 60&amp;nbsp;mL/min/1.73&amp;nbsp;m2 or a urine albumin:creatinine ratio ≥30&amp;nbsp;mg/g (3.4&amp;nbsp;mg/mmol) defines CKD. Overall in KEEP, the rates of identified CKD and
 self-reported CVD are 25.7% and 22.1%, respectively. The presence of CKD has been associated with younger ages of self-reported
 myocardial infarction and stroke. The combination of CVD and CKD in KEEP has been associated with shorter survival time. Finally,
 the presence of CVD or a prior history of coronary revascularization has been associated with modest...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4176418</comments>
            <pubDate>Sat, 13 Nov 2010 06:47:48 +0100</pubDate>
            <guid isPermaLink="false">4176418</guid>        </item>
        <item>
            <title>Insulin Analogues in the Management of the Pregnancy Complicated by Diabetes Mellitus</title>
            <link>http://www.medworm.com/index.php?rid=4165062&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4w3w5275x22n6608%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Since their introduction, insulin analogues are the preferred choice for short-acting insulin due to their superior pharmacologic
 profiles, leading to greater flexibility and convenience of dosing and, thus, greater patient satisfaction and improved quality
 of life. Over the past few years, clinical experience with insulin analogues in pregnancy has increased. The most studied,
 insulin lispro, has been shown to be a safe and clinically effective option in the treatment of the diabetic gravida. Studies
 of the other insulin analogues are limited, but promising. Further research is warranted to evaluate safety and efficacy of
 these analogues.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0160-0Authors
		Celeste P. Durnwald, Department of Obstetrics and Gynec...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4165062</comments>
            <pubDate>Fri, 12 Nov 2010 08:52:17 +0100</pubDate>
            <guid isPermaLink="false">4165062</guid>        </item>
        <item>
            <title>Cardiovascular Risk Reduction via Increasing HDL Cholesterol: The Promise of the dal-OUTCOMES Trial</title>
            <link>http://www.medworm.com/index.php?rid=4160447&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1m4jk2nw1rn27402%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11892-010-0165-8Authors
		Kyaw Soe, Division of Endocrinology, College of Medicine, SUNY-Downstate/Kings County Hospital Center, Brooklyn, NY 11203, USAAnis Alam, Division of Endocrinology, College of Medicine, SUNY-Downstate/Kings County Hospital Center, Brooklyn, NY 11203, USACharles Philip, Division of Endocrinology, College of Medicine, SUNY-Downstate/Kings County Hospital Center, Brooklyn, NY 11203, USAEdison Ruiz, Division of Endocrinology, College of Medicine, SUNY-Downstate/Kings County Hospital Center, Brooklyn, NY 11203, USAKeshwar Ramkissoon, Division of Endocrinology, College of Medicine, SUNY-Downstate/Kings County Hospital Center, Brooklyn, NY 11203, USASamy I. McFarlane, Division of Endocrinology, College of Medicine, SUNY-Downstate...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4160447</comments>
            <pubDate>Wed, 10 Nov 2010 17:29:28 +0100</pubDate>
            <guid isPermaLink="false">4160447</guid>        </item>
        <item>
            <title>Sleep Apnea and Diabetes: Insights into the Emerging Epidemic</title>
            <link>http://www.medworm.com/index.php?rid=4160448&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F800276213012n031%2F</link>
            <description>In this report, we discuss epidemiologic and clinical evidence suggesting that sleep apnea
 is involved in the pathogenesis of altered glucose metabolism. In light of current evidence, sleep apnea treatment should
 be incorporated into existing pharmacotherapeutic regimens for optimal management of diabetes among diabetic patients with
 sleep apnea to reduce associated cardiovascular risk. Suggestions to improve practice guidelines in the management of diabetic
 patients with sleep apnea are provided.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0164-9Authors
		A. Pandey, Brooklyn Health Disparities Center, Department of Medicine, SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 1199, Brooklyn, NY 11203-2098, USAM. Demede, Brooklyn Health Disparities Center, Department o...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4160448</comments>
            <pubDate>Wed, 10 Nov 2010 17:29:26 +0100</pubDate>
            <guid isPermaLink="false">4160448</guid>        </item>
        <item>
            <title>Promoting Breastfeeding Among Obese Women and Women with Gestational Diabetes Mellitus</title>
            <link>http://www.medworm.com/index.php?rid=4141251&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F843662815tu3x8h7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Breastfeeding has many health benefits for women and their babies, but particularly if the woman is obese and/or had a pregnancy
 affected with gestational diabetes mellitus (GDM). Women who have had GDM are at high risk for developing metabolic syndrome
 or type 2 diabetes, and their offspring are at greater risk for these metabolic disorders both in childhood and later in adulthood.
 There is considerable evidence that breastfeeding may attenuate these risks. The aim of this article is to present the most
 recent evidence on what is known about how breastfeeding can mitigate the adverse metabolic effects of obesity and GDM on
 both mother and child, and describe best practices that can support and sustain breastfeeding, particularly in racial/ethnic
 communities at ri...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4141251</comments>
            <pubDate>Fri, 05 Nov 2010 11:06:14 +0100</pubDate>
            <guid isPermaLink="false">4141251</guid>        </item>
        <item>
            <title>Sonographic Evaluation and the Pregnancy Complicated by Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=4141252&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk6562h6r38w1255h%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Sonography is a fundamental tool in the management of pregnancies affected by maternal diabetes. Purposeful use of ultrasound
 in each trimester provides an invaluable amount of information about the developing fetus including gestational age and growth
 patterns, anatomical structure and function, assessment of fetal well-being, and prediction of adverse outcome. There are
 great ongoing research efforts in this field of prenatal diagnosis and management, yet even more are needed.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0158-7Authors
		Jennifer M. McNamara, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Washington University School of Medicine, 4911 Barnes-Jewish Plaza, 5th Floor Maternity Building, Campus Box 8064, Saint...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4141252</comments>
            <pubDate>Tue, 02 Nov 2010 17:34:40 +0100</pubDate>
            <guid isPermaLink="false">4141252</guid>        </item>
        <item>
            <title>New Recommendations for the Diagnosis of Diabetes in Pregnancy</title>
            <link>http://www.medworm.com/index.php?rid=4135897&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F24201q2677vw0761%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11892-010-0157-8Authors
		Carol J. Homko, General Clinical Research Center, Temple University Hospital, 3401 North Broad Street, 4 West, Philadelphia, PA 19140, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4135897</comments>
            <pubDate>Tue, 02 Nov 2010 17:34:39 +0100</pubDate>
            <guid isPermaLink="false">4135897</guid>        </item>
        <item>
            <title>Obesity and Diabetes in Mothers and Their Children: Can We Stop the Intergenerational Cycle?</title>
            <link>http://www.medworm.com/index.php?rid=4090211&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F682635330u2r4671%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Obesity prevalence in the United States has reached an alarming level. Consequently, more young women are entering pregnancy
 with body mass indices of at least 30&amp;nbsp;kg/m2. While higher maternal weight entering pregnancy is related to several adverse pregnancy outcomes, some of the strongest
 and most compelling data to date have linked prepregnancy obesity to gestational diabetes mellitus (GDM). The mechanisms by
 which excess maternal weight influences metabolic dysfunction in pregnancy are similar to those in obese nonpregnant women;
 adipocytes are metabolically active and release a number of hormones implicated in insulin resistance. Heavier mothers are
 also more likely to have higher glucose levels that do not exceed the cutoff for GDM, but nevertheless predic...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4090211</comments>
            <pubDate>Thu, 21 Oct 2010 05:59:27 +0100</pubDate>
            <guid isPermaLink="false">4090211</guid>        </item>
        <item>
            <title>Resistant Hypertension in the High-Risk Metabolic Patient</title>
            <link>http://www.medworm.com/index.php?rid=4069024&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F682p118575668370%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The metabolic syndrome is a constellation of metabolic and vascular abnormalities that include insulin resistance with compensatory
 hyperinsulinemia, central or visceral obesity, hypertension, dyslipidemia, microalbuminuria, and oxidative stress as well
 as prothrombotic and inflammatory abnormalities that contribute to a hypercoagulable state and systemic endothelial dysfunction.
 Visceral adipose tissue is now known to secrete into the circulation a number of protein and nonprotein factors that regulate
 glucose metabolism in traditional insulin-sensitive tissue as well as nontraditional insulin-sensitive tissue including cardiovascular
 tissue. Collectively, this constellation of factors that lead to metabolic dysregulation contributes to a substantial risk
 for adv...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4069024</comments>
            <pubDate>Tue, 12 Oct 2010 16:52:50 +0100</pubDate>
            <guid isPermaLink="false">4069024</guid>        </item>
        <item>
            <title>The Genetics of Obesity</title>
            <link>http://www.medworm.com/index.php?rid=4051898&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk15ut0311r48770m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Obesity is a result of excess body fat accumulation. This excess is associated with adverse health effects such as CVD, type
 2 diabetes, and cancer. The development of obesity has an evident environmental contribution, but as shown by heritability
 estimates of 40% to 70%, a genetic susceptibility component is also needed. Progress in understanding the etiology has been
 slow, with findings largely restricted to monogenic, severe forms of obesity. However, technological and analytical advances
 have enabled detection of more than 20 obesity susceptibility loci. These contain genes suggested to be involved in the regulation
 of food intake through action in the central nervous system as well as in adipocyte function. These results provide plausible
 biological pathways ...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4051898</comments>
            <pubDate>Thu, 07 Oct 2010 16:54:44 +0100</pubDate>
            <guid isPermaLink="false">4051898</guid>        </item>
        <item>
            <title>Measures of Glycemic Variability and Links with Psychological Functioning</title>
            <link>http://www.medworm.com/index.php?rid=4037823&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff4k0770wp545640w%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The goal of this article is to review the recent literature on measures of glycemic variability, links between glycemic variability
 and psychological functioning, and methods for examining these links. A number of commonly used measures of glycemic variability
 are reviewed and compared, including recently proposed methods. Frequently used measures of glycemic variability are also
 discussed in the context of research that uses continuous glucose monitoring for the collection of blood glucose data. The
 results of previous studies that have examined the link between psychological functioning and glycemic variability within
 relatively short-term time frames are reviewed. Methods for examining glycemic variability and its link with psychological
 functioning are discuss...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4037823</comments>
            <pubDate>Mon, 04 Oct 2010 13:19:42 +0100</pubDate>
            <guid isPermaLink="false">4037823</guid>        </item>
        <item>
            <title>Patient Web Portals to Improve Diabetes Outcomes: A Systematic Review</title>
            <link>http://www.medworm.com/index.php?rid=4037824&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F321170kr57700563%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Patient web portals (PWPs), defined as the integration of electronic medical records and patient health records, have been
 related to enhanced patient outcomes. A literature review was conducted to characterize the design and evaluation of PWPs
 to improve health care processes and outcomes in diabetes. A summary of 26 articles revealed the positive impact PWPs have
 on patient outcomes, patient-provider communication, disease management, and access to and patient satisfaction with health
 care. Innovative and useful approaches included the evaluation of specific components of the PWPs, assessing the impact of
 PWPs on mediators of health behaviors, such as patient distress, identification of barriers to use, and patient willingness
 to pay for access. Future research ...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4037824</comments>
            <pubDate>Sat, 02 Oct 2010 05:56:58 +0100</pubDate>
            <guid isPermaLink="false">4037824</guid>        </item>
        <item>
            <title>Physiologic Characterization of Type 2 Diabetes–Related Loci</title>
            <link>http://www.medworm.com/index.php?rid=4026222&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkw88476nl17g2065%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;For the past two decades, genetics has been widely explored as a tool for unraveling the pathogenesis of diabetes. Many risk
 alleles for type 2 diabetes and hyperglycemia have been detected in recent years through massive genome-wide association studies
 and evidence exists that most of these variants influence pancreatic β-cell function. However, risk alleles in five loci seem
 to have a primary impact on insulin sensitivity. Investigations of more detailed physiologic phenotypes, such as the insulin
 response to intravenous glucose or the incretion hormones, are now emerging and give indications of more specific pathologic
 mechanisms for diabetes-related risk variants. Such studies have shed light on the function of some loci but also underlined
 the complex nature...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4026222</comments>
            <pubDate>Fri, 01 Oct 2010 07:03:06 +0100</pubDate>
            <guid isPermaLink="false">4026222</guid>        </item>
        <item>
            <title>Biological Basis of Depression in Adults with Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=4005733&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0x433764523p5182%2F</link>
            <description>The objectives of this review are to summarize and review the recent evidence showing alterations
 of these three biological systems—HPA axis, SNS, and inflammatory cascade—in depression, diabetes, and diabetes-related risk
 factors.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0148-9Authors
		Shivam Champaneri, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD USAGary S. Wand, Department of Medicine and Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD USASaurabh S. Malhotra, Department of Medicine, Indiana University, Indianapolis, IN USASarah S. Casagrande, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD USASherita Hill Golden, Division of Endocrinology and Metabolism, J...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4005733</comments>
            <pubDate>Mon, 27 Sep 2010 16:52:40 +0100</pubDate>
            <guid isPermaLink="false">4005733</guid>        </item>
        <item>
            <title>From Genetic Association to Molecular Mechanism</title>
            <link>http://www.medworm.com/index.php?rid=4005735&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F718v213705325453%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Over the past 3&amp;nbsp;years, there has been a dramatic increase in the number of confirmed type 2 diabetes (T2D) susceptibility
 loci, most arising through the implementation of genome-wide association studies (GWAS). However, progress toward the understanding
 of disease mechanisms has been slowed by modest effect sizes and the fact that most GWAS signals map away from coding sequence:
 the presumption is that their effects are mediated through regulation of nearby transcripts, but the identities of the genes
 concerned are often far from clear. In this review we describe the progress that has been made to date in translating association
 signals into molecular mechanisms with a focus on the most tractable signals (eg, KCNJ11/ABCC8, SLC30A8, GCKR) and those in which hum...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4005735</comments>
            <pubDate>Mon, 27 Sep 2010 16:52:39 +0100</pubDate>
            <guid isPermaLink="false">4005735</guid>        </item>
        <item>
            <title>Molecular Function of TCF7L2: Consequences of TCF7L2 Splicing for Molecular Function and Risk for Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=4005734&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F72056669h6448v16%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;
 TCF7L2 harbors the variant with the strongest effect on type 2 diabetes (T2D) identified to date, yet the molecular mechanism as
 to how variation in the gene increases the risk for developing T2D remains elusive. The phenotypic changes associated with
 the risk genotype suggest that T2D arises as a consequence of reduced islet mass and/or impaired function, and it has become
 clear that TCF7L2 plays an important role for several vital functions in the pancreatic islet. TCF7L2 comprises 17 exons, five of which are alternative (ie, exons 4 and 13–16). In pancreatic islets four splice variants of TCF7L2 are predominantly expressed. The regulation of these variants and the functional consequences at the protein level are still
 poorly understood. A clear picture of the...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4005734</comments>
            <pubDate>Mon, 27 Sep 2010 16:52:39 +0100</pubDate>
            <guid isPermaLink="false">4005734</guid>        </item>
        <item>
            <title>Preventing Poor Psychological and Health Outcomes in Pediatric Type 1 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=3966829&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F052r7777701u3875%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Youth with type 1 diabetes are at high risk for psychosocial morbidities. These include depression, disturbed eating behavior,
 family conflict, poor health-related quality of life, low self-efficacy, and difficulty with medical adherence and metabolic
 control. A number of prevention interventions have been studied in this group, with the overall goal of improving adaptation
 and coping skills. This paper reviews the current research aimed at preventing poor outcomes in youth with type 1 diabetes
 and recommends simple interventions that can be added to clinical encounters. Recommendations for future psychosocial prevention
 studies are also discussed.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0145-zAuthors
		Naomi R. Fogel, Children’s Memorial Hospital...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3966829</comments>
            <pubDate>Sat, 11 Sep 2010 15:39:45 +0100</pubDate>
            <guid isPermaLink="false">3966829</guid>        </item>
        <item>
            <title>Genetics of Diabetes Complications</title>
            <link>http://www.medworm.com/index.php?rid=3966830&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp7258u405876322n%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A large body of evidence indicates that the risk for developing chronic diabetic complications is under the control of genetic
 factors. Previous studies using a candidate gene approach have uncovered a number of genetic loci that may shape this risk,
 such as the VEGF gene for retinopathy, the ELMO1 gene for nephropathy, and the ADIPOQ gene for coronary artery disease. Recently, a new window has opened on identifying these genes through genome-wide association
 studies. Such systematic approach has already led to the identification of a major locus for coronary artery disease on 9p21
 as well three potential genes for nephropathy on 7p, 11p, and 13q. Further insights are expected from a broader application
 of this strategy. It is anticipated that the identification of...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3966830</comments>
            <pubDate>Sat, 11 Sep 2010 15:39:44 +0100</pubDate>
            <guid isPermaLink="false">3966830</guid>        </item>
        <item>
            <title>Islet Versus Pancreas Transplantation in Type 1 Diabetes: Competitive or Complementary?</title>
            <link>http://www.medworm.com/index.php?rid=3955876&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq5l1224270014762%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Whole organ pancreas and pancreatic islet transplantation are currently the only forms of clinically available β-cell replacement.
 Both therapeutic options can provide good glycemic control and prevention or stabilization of diabetic complications, but
 at the price of permanent immunosuppression. Therefore, the indication for transplantation of type 1 diabetes patients must
 be balanced carefully and should be restricted to a subgroup of patients with extreme lability of metabolic control and frequent
 hypoglycemia despite optimal medical therapy.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0146-yAuthors
		Barbara Ludwig, Department of Medicine III, University Hospital Carl Gustav Carus, Fetscherstr. 74, 01307 Dresden, GermanyStefan Ludwig, Department of ...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3955876</comments>
            <pubDate>Thu, 09 Sep 2010 16:46:44 +0100</pubDate>
            <guid isPermaLink="false">3955876</guid>        </item>
        <item>
            <title>Getting (the Most) Out of the Research Business: Interventions for Youth with T1DM</title>
            <link>http://www.medworm.com/index.php?rid=3948249&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F84g363p012228882%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We review research on psychosocial interventions to improve outcomes for youth with type 1 diabetes mellitus. Specifically,
 we discuss individual- and small group–focused, family-focused, group-focused, and other interventions. After reviewing extant
 research in each area, we discuss how the current evidence base may be used to inform clinical practice. Finally, we conclude
 by discussing variations in effects of interventions on different outcomes (eg, glycemic control, family functioning) and
 how to consider this evidence when selecting treatments to transport into clinical settings.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0142-2Authors
		Michael A. Harris, Pediatrics and Psychiatry, Division of Psychology, Child Development &amp; Rehabilitation Cente...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3948249</comments>
            <pubDate>Wed, 08 Sep 2010 05:27:51 +0100</pubDate>
            <guid isPermaLink="false">3948249</guid>        </item>
        <item>
            <title>Preconception Counseling for Adolescent Females with Type 1 Diabetes: The READY-Girls Program</title>
            <link>http://www.medworm.com/index.php?rid=3948250&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm44347231r338116%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11892-010-0144-0Authors
		Korey K. Hood, Center for Treatment Adherence, Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children’s Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, 3333 Burnet Avenue, MLC 7039, Cincinnati, OH 45229, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3948250</comments>
            <pubDate>Tue, 07 Sep 2010 17:25:35 +0100</pubDate>
            <guid isPermaLink="false">3948250</guid>        </item>
        <item>
            <title>The Genetics of Insulin Resistance: Where’s Waldo?</title>
            <link>http://www.medworm.com/index.php?rid=3948251&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F57g7616322326x96%2F</link>
            <description>We present alternative views that may partly explain the apparent dearth of insulin resistance loci contributing
 to genetic susceptibility to type 2 diabetes, rather than focus on traditional issues such as study design and sampling, which
 have been addressed elsewhere.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0143-1Authors
		Richard M. Watanabe, Departments of Preventive Medicine and Physiology &amp; Biophysics, Keck School of Medicine of USC, 1540 Alcazar Street, CHP-220, Los Angeles, CA 90089-9011, USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3948251</comments>
            <pubDate>Tue, 07 Sep 2010 17:25:34 +0100</pubDate>
            <guid isPermaLink="false">3948251</guid>        </item>
        <item>
            <title>Loss and Preservation of β-Cell Function: Two Treatment Regimes Targeting T or B Lymphocytes</title>
            <link>http://www.medworm.com/index.php?rid=3866034&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm5117pm1634k6914%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11892-010-0141-3Authors
		Anette-G. Ziegler, Institut für Diabetesforschung, Helmholtz Zentrum München, German Research Center for Environmental Health &amp; Forschergruppe Diabetes, Ingolstaedter Landstrasse 1, 85764 Neuherberg, GermanyMarkus Walter, Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3866034</comments>
            <pubDate>Wed, 11 Aug 2010 19:09:30 +0100</pubDate>
            <guid isPermaLink="false">3866034</guid>        </item>
        <item>
            <title>Pediatric Islet Autotransplantation: Indication, Technique, and Outcome</title>
            <link>http://www.medworm.com/index.php?rid=3818379&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4320554k8628g536%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Chronic pancreatitis is a rare disease in childhood. However, when severe, a total pancreatectomy may be the only option to
 relieve pain and restore quality of life. An islet autotransplant performed at the time of pancreatectomy can prevent or minimize
 the postsurgical diabetes that would otherwise result from pancreatectomy alone. In this procedure, the resected pancreas
 is mechanically disrupted and enzymatically digested to separate the islets from the surrounding exocrine tissue, and the
 isolated islets are infused into the portal vein and engraft in the liver. Because patients are receiving their own tissue,
 no immunosuppression is required. Islet autotransplant is successful in two thirds of children—these patients are insulin
 independent or require littl...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3818379</comments>
            <pubDate>Mon, 02 Aug 2010 19:24:32 +0100</pubDate>
            <guid isPermaLink="false">3818379</guid>        </item>
        <item>
            <title>Virus Infections and Type 1 Diabetes Risk</title>
            <link>http://www.medworm.com/index.php?rid=3818380&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu71j106384t444n4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Common intestinal infections caused by human enteroviruses (HEVs) are considered major environmental factors predisposing
 to type 1 diabetes (T1D). In spite of the active research of the field, the HEV-induced pathogenetic processes are poorly
 understood. Recently, after the first documented report on HEV infections in the pancreatic islets of deceased T1D patients,
 several groups became interested in the issue and studied valuable human material, the autopsy pancreases of diabetic and/or
 autoantibody-positive patients for HEV infections. In this review, the data on HEV infections in human pancreatic islets are
 discussed with special reference to the methods used. Likewise, mechanisms that could increase viral access to the pancreas
 are reviewed and discussed.
 
 ...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3818380</comments>
            <pubDate>Mon, 02 Aug 2010 19:24:31 +0100</pubDate>
            <guid isPermaLink="false">3818380</guid>        </item>
        <item>
            <title>Immune Intervention in Children with Type 1 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=3800255&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl3w0753j50406u06%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Not only T cells but also B cells play a role in the autoimmune process. Both monoclonal antiCD3 and antiCD20 antibodies seem
 efficacious. However, such treatments need to be refined to minimize adverse events. Use of autoantigens to create tolerance
 is a concept with great potential. GAD65 treatment has shown efficacy without adverse events thus far, and administration
 of the insulin B chain shows interesting immunologic effects. Other more or less speculative approaches to modulate the immune
 process need further studies with good design. Risks that are too serious cannot be motivated. In addition, as the β cells
 may die even though the autoimmune process is stopped, protective measures may be valuable (eg, active insulin treatment,
 and perhaps interleukin-1 re...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3800255</comments>
            <pubDate>Wed, 28 Jul 2010 17:45:51 +0100</pubDate>
            <guid isPermaLink="false">3800255</guid>        </item>
        <item>
            <title>Islet Transplantation: Alternative Sites</title>
            <link>http://www.medworm.com/index.php?rid=3800256&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe8l74tj46854w8q1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The portal vein is currently the site of choice for clinical islet transplantation, even though it is far from being an ideal
 site. Low oxygen tension and the induction of an inflammatory response impair islet implantation and lead to significant early
 loss. Even if enough islets survive the early implantation period to render insulin independence, few patients maintain it.
 Therefore, the search for an ideal site for islet transplantation continues. Experimentally, islets have been transplanted
 into the portal vein, kidney subcapsule, spleen, pancreas, peritoneum, omentum, gastrointestinal wall, testis, thymus, bone
 marrow, anterior chamber of the eye, cerebral ventricles, and subcutaneous and intramuscular spaces. Some of these sites are
 suitable for gathering sc...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3800256</comments>
            <pubDate>Tue, 27 Jul 2010 19:49:56 +0100</pubDate>
            <guid isPermaLink="false">3800256</guid>        </item>
        <item>
            <title>Virus Infections: Lessons from Pancreas Histology</title>
            <link>http://www.medworm.com/index.php?rid=3800257&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6220x5h93581837q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Type 1 diabetes mellitus is a chronic autoimmune disease resulting from the progressive immune-mediated destruction of pancreatic
 β cells in genetically susceptible individuals, with the likely contribution of environmental factors, among which viruses
 have been extensively studied. The pathologic hallmark of the disease is insulitis—a process characterized by islet infiltration
 of immunocompetent cells that has been well characterized in animal models of islet autoimmunity, and to a lesser extent,
 in humans. Insulitis characterization has provided valuable information to gain insights into the disease pathogenesis. We
 review the recent literature on the viral contribution to β-cell destruction and dysfunction in type 1 diabetes, with particular
 reference to t...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3800257</comments>
            <pubDate>Tue, 27 Jul 2010 19:49:55 +0100</pubDate>
            <guid isPermaLink="false">3800257</guid>        </item>
        <item>
            <title>The Role of Kidney-Pancreas Transplantation in Diabetic Kidney Disease</title>
            <link>http://www.medworm.com/index.php?rid=3796403&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg843246v921q1jl6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;For patients with type 1 diabetes, innovations in insulin formulations and delivery have improved the ability to achieve excellent
 blood glucose control. However, it is uncommon to achieve euglycemia, particularly while avoiding complications arising from
 hypoglycemia. Pancreas transplantation remains the only broadly applied treatment strategy that can result in normalization
 of blood glucose, but this must be weighed against the risks of a surgical procedure and subsequent immunosuppression. To
 improve this risk/benefit ratio, pancreas transplantation is typically performed in patients with kidney failure who are to
 undergo kidney transplantation and immunosuppression (simultaneous pancreas-kidney transplant) or who have undergone kidney
 transplant and are oblig...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3796403</comments>
            <pubDate>Mon, 26 Jul 2010 21:53:58 +0100</pubDate>
            <guid isPermaLink="false">3796403</guid>        </item>
        <item>
            <title>Novel Gene Associations in Type 1 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=3778296&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq54l726x60875606%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recent genome-wide association studies have been able to identify multiple new gene loci affecting type 1 diabetes susceptibility,
 but the impact of these new defined loci seems to decrease in parallel with their number. The HLA gene region remains the
 main nominator of genetic susceptibility, although the identity of important genes and especially the mechanisms of their
 action are still largely unclear. Products of HLA and most other known risk genes are involved in regulation of the immune
 system in accordance with the autoimmune nature of the disease. The multitude of genes involved in the pathogenesis implies
 complex pathways where multiple steps in each may be essential in turning the balance of immune response to β-cell destructing
 autoimmunity.
 
 
	Conte...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3778296</comments>
            <pubDate>Mon, 19 Jul 2010 17:58:51 +0100</pubDate>
            <guid isPermaLink="false">3778296</guid>        </item>
        <item>
            <title>The Cardinal Features of Recurrent Autoimmunity in Simultaneous Pancreas-Kidney Transplant Recipients</title>
            <link>http://www.medworm.com/index.php?rid=3778297&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8t30x40523271n11%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11892-010-0134-2Authors
		Boaz Hirshberg, AstraZeneca Pharmaceuticals Clinical Research Room C3C-718 A, 1800 Concord Pike PO Box 15437 Wilmington DE 19850-5437 USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3778297</comments>
            <pubDate>Mon, 19 Jul 2010 11:59:48 +0100</pubDate>
            <guid isPermaLink="false">3778297</guid>        </item>
        <item>
            <title>Infant and Childhood Diet and Type 1 Diabetes Risk: Recent Advances and Prospects</title>
            <link>http://www.medworm.com/index.php?rid=3778298&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy5754584k2319578%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Type 1 diabetes is a chronic autoimmune disease characterized by a preclinical period of autoimmunity. It is well accepted
 that both genetic and environmental factors contribute to disease risk. Given that type 1 diabetes, and its preclinical autoimmunity,
 appear early in life, infant and childhood diet have been implicated as potential initiating exposures in the etiology of
 the disease. Several publications in the past year have provided further evidence for existing hypotheses regarding the roles
 of wheat, cow’s milk, omega-3 fatty acids, and the maternal diet during pregnancy. However, inconsistencies in findings between
 studies suggest the need for collaboration and standardization of study methods to move forward in research in this area.
 One such example ...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3778298</comments>
            <pubDate>Mon, 19 Jul 2010 11:59:20 +0100</pubDate>
            <guid isPermaLink="false">3778298</guid>        </item>
        <item>
            <title>The Value of National Diabetes Registries: SEARCH for Diabetes in Youth Study</title>
            <link>http://www.medworm.com/index.php?rid=3773941&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx138t1x6897n5m61%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Diabetes mellitus is one of the most common severe chronic diseases of childhood. Much of our knowledge of the epidemiology
 of diabetes in young people has been generated by large collaborative efforts based on standardized registry data, such as
 the DIAMOND Project worldwide and the EURODIAB study in Europe. These registries showed that although at the start of the
 20th century childhood diabetes was rare, by the end of the century a steady increase in incidence had been reported in many
 parts of the world. However, epidemiologic data for temporal trends in pediatric diabetes are still lacking or are minimal
 for most of the global population of youth, including in the United States. In addition, the epidemiology of diabetes in youth
 is changing. As youth are beco...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3773941</comments>
            <pubDate>Fri, 16 Jul 2010 07:49:28 +0100</pubDate>
            <guid isPermaLink="false">3773941</guid>        </item>
        <item>
            <title>Visual Dysfunction Associated with Diabetic Retinopathy</title>
            <link>http://www.medworm.com/index.php?rid=3773940&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F757543861m4q63n7%2F</link>
            <description>This article reviews the impact of diabetes mellitus on inner
 and outer retinal visual and electrophysiologic function and advocates for a multimodal approach to the study of diabetic
 retinopathy.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0132-4Authors
		Gregory R. Jackson, Penn State College of Medicine Penn State Hershey Eye Center, Department of Ophthalmology 500 University Drive, HU19 Hershey PA 17033 USAAlistair J. Barber, Penn State College of Medicine Penn State Hershey Eye Center, Department of Ophthalmology 500 University Drive, HU19 Hershey PA 17033 USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3773940</comments>
            <pubDate>Fri, 16 Jul 2010 07:49:28 +0100</pubDate>
            <guid isPermaLink="false">3773940</guid>        </item>
        <item>
            <title>Optical Coherence Tomography Imaging for Diabetic Retinopathy and Macular Edema</title>
            <link>http://www.medworm.com/index.php?rid=3673724&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb8j6031vj5410381%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Optical coherence tomography (OCT) is a noninvasive imaging modality that uses low-coherent interferometry to visualize an
 optical cross-section of biological tissues. Over the past two decades, the ability to perform OCT imaging of the neural retina
 has afforded clinicians and researchers a highly reproducible method of diagnosing and following diabetic macular edema (DME)
 that compares favorably to other methods of DME assessment such as clinical examination and fundus photography. Although central
 subfield mean thickness has been the OCT parameter most commonly used to evaluate DME in clinical research trials, OCT also
 allows evaluation of morphologic changes that occur in DME, including compact retinal thickening, intraretinal cystic changes,
 subretinal fluid,...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3673724</comments>
            <pubDate>Thu, 17 Jun 2010 09:30:41 +0100</pubDate>
            <guid isPermaLink="false">3673724</guid>        </item>
        <item>
            <title>The Role of Adipose Tissue and Lipotoxicity in the Pathogenesis of Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=3673725&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F38751853045x5365%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The widespread epidemics of obesity and type 2 diabetes mellitus (T2DM) suggest that both conditions are closely linked. An
 increasing body of evidence has shifted our view of adipose tissue from a passive energy depot to a dynamic “endocrine organ”
 that tightly regulates nutritional balance by means of a complex crosstalk of adipocytes with their microenvironment. Dysfunctional
 adipose tissue, particularly as observed in obesity, is characterized by adipocyte hypertrophy, macrophage infiltration, impaired
 insulin signaling, and insulin resistance. The result is the release of a host of inflammatory adipokines and excessive amounts
 of free fatty acids that promote ectopic fat deposition and lipotoxicity in muscle, liver, and pancreatic β cells. This review
 fo...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3673725</comments>
            <pubDate>Thu, 17 Jun 2010 09:30:40 +0100</pubDate>
            <guid isPermaLink="false">3673725</guid>        </item>
        <item>
            <title>Diabetes, Anemia and CKD: Why TREAT?</title>
            <link>http://www.medworm.com/index.php?rid=3653995&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl468373875564218%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The triad of diabetes mellitus, anemia, and chronic kidney disease (CKD) define a group of patients at high risk for death
 and cardiovascular complications. The approval of epoetin alfa in 1989 transformed the treatment of anemia in patients with
 CKD. However, evidence has emerged from randomized controlled trials that correcting anemia with erythropoiesis-stimulating
 agents in CKD patients is associated with increased risk. Most recently, the TREAT (Trial to Reduce Cardiovascular Events
 With Aranesp Therapy) study of anemic type 2 diabetic patients with CKD reported that treatment with darbepoetin conferred
 no benefit in mortality or in attenuating cardiovascular or renal events. Instead, there was a twofold higher rate of stroke
 and thromboembolic complications ...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3653995</comments>
            <pubDate>Thu, 10 Jun 2010 17:42:47 +0100</pubDate>
            <guid isPermaLink="false">3653995</guid>        </item>
        <item>
            <title>Plasma Kallikrein and Diabetic Macular Edema</title>
            <link>http://www.medworm.com/index.php?rid=3653996&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh36083xg75307772%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recent proteomic studies have identified components of the kallikrein kinin system, including plasma kallikrein, factor XII,
 and kininogen, in vitreous obtained from individuals with advanced diabetic retinopathy. In rodent models, activation of plasma
 kallikrein in vitreous increases retinal vascular permeability; whereas inhibition of the kallikrein kinin system reduces
 retinal leakage induced by diabetes and hypertension. These findings suggest that intraocular activation of the plasma kallikrein
 pathway may contribute to excessive retinal vascular permeability that can lead to diabetic macular edema. The kallikrein
 kinin system contains two separate and independently regulated serine proteases that generate bradykinin peptides: plasma
 kallikrein and tissue kal...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3653996</comments>
            <pubDate>Wed, 09 Jun 2010 20:14:19 +0100</pubDate>
            <guid isPermaLink="false">3653996</guid>        </item>
        <item>
            <title>Use of Medications to Lower Urine Protein Level in Patients With Diabetic Kidney Disease</title>
            <link>http://www.medworm.com/index.php?rid=3650022&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnt2511654x52517x%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11892-010-0125-3Authors
		Robert C. Stanton, Joslin Diabetes Center Division of Nephrology One Joslin Place Boston MA 02215 USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3650022</comments>
            <pubDate>Mon, 07 Jun 2010 17:15:53 +0100</pubDate>
            <guid isPermaLink="false">3650022</guid>        </item>
        <item>
            <title>Dual Renin-Angiotensin-Aldosterone System Blockade for Diabetic Kidney Disease</title>
            <link>http://www.medworm.com/index.php?rid=3650024&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm154p835629l717n%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Blockade of the renin-angiotensin-aldosterone system (RAAS) prevents the development and progression of diabetic kidney disease
 (DKD). It is controversial whether the simultaneous use of two RAAS inhibitors (ie, dual RAAS blockade) further improves renal
 outcomes. This review examines the scientific rationale and current clinical evidence addressing the use of dual RAAS blockade
 to prevent and treat DKD. It is concluded that dual RAAS blockade should not be routinely applied to patients with low or
 moderate risk of progressive kidney disease (normoalbuminuria or microalbuminuria with preserved glomerular filtration rate).
 For patients with high risk of progressive kidney disease (substantial albuminuria or impaired glomerular filtration rate),
 clinicians should ca...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3650024</comments>
            <pubDate>Mon, 07 Jun 2010 17:15:52 +0100</pubDate>
            <guid isPermaLink="false">3650024</guid>        </item>
        <item>
            <title>Management of Hypertriglyceridemia in the Diabetic Patient</title>
            <link>http://www.medworm.com/index.php?rid=3650023&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F64677141125214hq%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The hypertriglyceridemia of diabetes can be classified into mild to moderate (triglycerides between 150–499&amp;nbsp;mg/dL) and severe
 hypertriglyceridemia (triglycerides ≥500&amp;nbsp;mg/dL). As in any other individuals with hypertriglyceridemia, secondary causes need
 to be excluded. The management of severe hypertriglyceridemia (chylomicronemia syndrome) includes aggressive reduction of
 triglycerides with intravenous insulin, fibrates, omega-3 fatty acids, and/or niacin therapy to avert the risk of pancreatitis.
 In patients with mild to moderate hypertriglyceridemia, the treatment of choice is statin therapy to achieve the low-density
 lipoprotein (LDL) and non-high-density lipoprotein (HDL) target goals. The evidence base would favor niacin therapy in combination
 wi...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3650023</comments>
            <pubDate>Mon, 07 Jun 2010 17:15:52 +0100</pubDate>
            <guid isPermaLink="false">3650023</guid>        </item>
        <item>
            <title>Diabetic Foot Disease in People with Advanced Nephropathy and Those on Renal Dialysis</title>
            <link>http://www.medworm.com/index.php?rid=3650025&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd35qk82357r1h0q5%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Among the spectrum of risk for diabetic foot disease conferred by chronic kidney disease (CKD), end-stage renal disease (ESRD)
 has emerged as a novel independent risk factor. Apart from the classical triad of neuropathy, infection, and peripheral arterial
 disease that operate in these individuals, the risk is further compounded by inadequate foot self-care by patients and by
 dialysis centers not providing onsite foot care, as medical priorities are diverted to the dialysis itself. Consequently,
 the burden of diabetic foot disease has increased in the CKD and ESRD population as exemplified by high ulceration, amputation,
 and foot-related mortality rates. Current guidelines on foot care in diabetes should recognize advanced CKD and ESRD/dialysis
 as a separate risk f...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3650025</comments>
            <pubDate>Mon, 07 Jun 2010 17:15:51 +0100</pubDate>
            <guid isPermaLink="false">3650025</guid>        </item>
        <item>
            <title>Hyperbaric Oxygen in the Management of Chronic Diabetic Foot Ulcers</title>
            <link>http://www.medworm.com/index.php?rid=3583059&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F114p7u2664888107%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11892-010-0121-7Authors
		Andrew J. M. Boulton, Manchester Diabetes Centre 193 Hathersage Road Manchester M13 0JE UK
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3583059</comments>
            <pubDate>Wed, 19 May 2010 18:02:44 +0100</pubDate>
            <guid isPermaLink="false">3583059</guid>        </item>
        <item>
            <title>DCCT and EDIC Studies in Type 1 Diabetes: Lessons for Diabetic Neuropathy Regarding Metabolic Memory and Natural History</title>
            <link>http://www.medworm.com/index.php?rid=3565038&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F964768u000042742%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The DCCT/EDIC (Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications) provides
 a comprehensive characterization of the natural history of diabetic neuropathy in patients with type 1 diabetes and provides
 insight into the impact of intensive insulin therapy in disease progression. The lessons learned about the natural history
 of distal symmetrical polyneuropathy and cardiovascular autonomic neuropathy and the impact of glycemic control on neuropathy
 are discussed in this review.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0120-8Authors
		Rodica Pop-Busui, University of Michigan Medical School Department of Internal Medicine Ann Arbor MI USAWilliam H. Herman, University of Michigan Medical School Department of I...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3565038</comments>
            <pubDate>Thu, 13 May 2010 08:58:57 +0100</pubDate>
            <guid isPermaLink="false">3565038</guid>        </item>
        <item>
            <title>Gestational Diabetes Mellitus: Can We Reach Consensus?</title>
            <link>http://www.medworm.com/index.php?rid=3539921&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp2t90v4k27071313%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11892-010-0117-3Authors
		Carol J. Homko, Temple University School of Medicine Departments of Medicine and OB/GYN 3401 North Broad Street, 4 West Philadelphia PA 19140 USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3539921</comments>
            <pubDate>Wed, 05 May 2010 07:57:17 +0100</pubDate>
            <guid isPermaLink="false">3539921</guid>        </item>
        <item>
            <title>Bariatric Surgery as Treatment for Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=3539922&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd13r8583w44175t4%2F</link>
            <description>Content Type Journal ArticleCategory Invited CommentaryDOI 10.1007/s11892-010-0118-2Authors
		George L. Blackburn, Harvard Medical School Division of Nutrition Boston MA USASamuel B. Wollner, Beth Israel Deaconess Medical Center Center for the Study of Nutrition Medicine Boston MA USADaniel B. Jones, Beth Israel Deaconess Medical Center Section Minimally Invasive Surgery 330 Brookline Avenue Boston MA 02215 USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3539922</comments>
            <pubDate>Tue, 04 May 2010 07:49:09 +0100</pubDate>
            <guid isPermaLink="false">3539922</guid>        </item>
        <item>
            <title>Common Genetic Variation Influences the Heterogeneity of Response to Oral Glucose</title>
            <link>http://www.medworm.com/index.php?rid=3531630&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpv82401k3560g41v%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11892-010-0119-1Authors
		Adrian Vella, Mayo Clinic College of Medicine Department of Endocrinology 200 First Street SW Rochester MN 55905 USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3531630</comments>
            <pubDate>Sat, 01 May 2010 07:14:17 +0100</pubDate>
            <guid isPermaLink="false">3531630</guid>        </item>
        <item>
            <title>Defects in Insulin Secretion and Action in the Pathogenesis of Type 2 Diabetes Mellitus</title>
            <link>http://www.medworm.com/index.php?rid=3481602&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg38m64110527m653%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Type 2 diabetes mellitus (T2DM) is characterized by defects in insulin action and insulin secretion. Although insulin resistance
 manifests early during the prediabetic state, a failing β-cell function unable to overcome insulin resistance at target tissues
 determines the onset of T2DM. This review focuses on recent advances in the molecular mechanisms of insulin resistance and
 β-cell dysfunction. The role of mitochondrial dysfunction, impaired regulation of the enteroinsular axis, and endoplasmic
 reticulum stress are currently the subjects of intensive research. In addition, the adipose tissue has emerged as a major
 endocrine organ that secretes a growing list of adipocytokines with diverse central and peripheral metabolic effects. The
 role of a growing number o...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3481602</comments>
            <pubDate>Wed, 14 Apr 2010 16:54:11 +0100</pubDate>
            <guid isPermaLink="false">3481602</guid>        </item>
        <item>
            <title>Metabolic Syndrome in Blacks: Are the Criteria Right?</title>
            <link>http://www.medworm.com/index.php?rid=3469383&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4320422q86868820%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Blacks have a lower prevalence of metabolic syndrome (MetS) that can be partly ascribed to the lower prevalent rates of some
 major components of MetS, namely the lower serum triglycerides and higher high-density lipoprotein cholesterol levels in blacks
 when compared with whites. Blacks manifest greater insulin resistance, the pivotal lesion underpinning MetS than whites. However,
 the relationships among insulin resistance and cardiovascular disease (CVD) risk factors are weaker in blacks than whites.
 The international bodies have recommended the use of European-based cutoff points for MetS for blacks. However, with the emerging
 inconsistencies in the association of insulin resistance and CVD risk factors in blacks, the use of these definitions and
 the cutoff point...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3469383</comments>
            <pubDate>Mon, 12 Apr 2010 17:59:09 +0100</pubDate>
            <guid isPermaLink="false">3469383</guid>        </item>
        <item>
            <title>The Contribution of Enteroinsular Hormones to the Pathogenesis of Type 2 Diabetes Mellitus</title>
            <link>http://www.medworm.com/index.php?rid=3450982&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn126r5856j71vllu%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The gastrointestinal hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), termed
 incretins, are essential regulators of normal glucose homeostasis. Research indicates that the incretin effect is impaired
 in type 2 diabetes, and this seems to be a consequence rather than a cause of type 2 diabetes. This review describes the defects
 in the incretin system seen in diabetic patients and discusses the potential roles of GIP and GLP-1 in the pathogenesis of
 type 2 diabetes. In addition, new information on clinical applications that exploit the enteroinsular axis to control blood
 glucose is discussed.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0114-6Authors
		Dima L. Diab, University of Cincinnati Division of Endocr...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3450982</comments>
            <pubDate>Mon, 05 Apr 2010 21:36:27 +0100</pubDate>
            <guid isPermaLink="false">3450982</guid>        </item>
        <item>
            <title>Gestational Diabetes Screening After HAPO: Has Anything Changed?</title>
            <link>http://www.medworm.com/index.php?rid=3430798&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0386396237723783%2F</link>
            <description>This article
 summarizes the current state of screening for gestational diabetes
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0109-3Authors
		Wadia R. Mulla, Temple University School of Medicine Department of OB/GYN 3401 North Broad Street Philadelphia PA 19140 USATasmia Q. Henry, Temple University School of Medicine Department of OB/GYN 3401 North Broad Street Philadelphia PA 19140 USACarol J. Homko, Temple University School of Medicine Department of OB/GYN 3401 North Broad Street Philadelphia PA 19140 USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3430798</comments>
            <pubDate>Wed, 31 Mar 2010 16:44:50 +0100</pubDate>
            <guid isPermaLink="false">3430798</guid>        </item>
        <item>
            <title>Cinnamon as a Supplemental Treatment for Impaired Glucose Tolerance and Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=3430799&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjg430216p56w606q%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11892-010-0106-6Authors
		Amy D. Otto, University of Pittsburgh Physical Activity and Weight Management Research Center Suite 600 Birmingham Towers, 2100 Wharton Street Pittsburgh PA 15203 USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3430799</comments>
            <pubDate>Wed, 31 Mar 2010 05:56:50 +0100</pubDate>
            <guid isPermaLink="false">3430799</guid>        </item>
        <item>
            <title>Postpartum Screening Following GDM: How Well Are We Doing?</title>
            <link>http://www.medworm.com/index.php?rid=3430800&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhn7868x743v4uw57%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Once diagnosed with gestational diabetes mellitus (GDM), a woman has a sevenfold increased risk of developing type 2 diabetes
 relative to women who do not have diabetes during pregnancy. In addition, up to one third of women with GDM have overt diabetes,
 impaired fasting glucose, or impaired glucose tolerance identified during postpartum glucose screening completed within 6
 to 12&amp;nbsp;weeks. Therefore, the American Diabetes Association, the World Health Organization, and the American College of Obstetricians
 and Gynecologists currently recommend postpartum glucose screening following GDM. However, despite this recommendation, in
 many settings the majority of women with GDM fail to return for postpartum glucose testing. Studies conducted to date have
 not comprehens...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3430800</comments>
            <pubDate>Wed, 31 Mar 2010 05:56:48 +0100</pubDate>
            <guid isPermaLink="false">3430800</guid>        </item>
        <item>
            <title>The Association Between Depression and Diabetes in the Perinatal Period</title>
            <link>http://www.medworm.com/index.php?rid=3422257&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj73h4mh52006t00r%2F</link>
            <description>This article reviews the four most relevant epidemiologic papers that examined the association between depression
 and diabetes in the perinatal period and makes recommendations for future studies about how best to examine the association
 between these disorders during the perinatal period.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0108-4Authors
		Laura J. Rasmussen-Torvik, University of Minnesota School of Public Health Division of Epidemiology and Community Health 1300 South Second Street, Suite 300 Minneapolis MN 55454-1015 USABernard L. Harlow, University of Minnesota School of Public Health Division of Epidemiology and Community Health 1300 South Second Street, Suite 300 Minneapolis MN 55454-1015 USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3422257</comments>
            <pubDate>Mon, 29 Mar 2010 17:15:19 +0100</pubDate>
            <guid isPermaLink="false">3422257</guid>        </item>
        <item>
            <title>Glucose Monitoring During Pregnancy</title>
            <link>http://www.medworm.com/index.php?rid=3422258&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh57517j45265234n%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Self-monitoring of blood glucose in women with mild gestational diabetes has recently been proven to be useful in reducing
 the rates of fetal overgrowth and gestational weight gain. However, uncertainty remains with respect to the optimal frequency
 and timing of self-monitoring. A continuous glucose monitoring system may have utility in pregnant women with insulin-treated
 diabetes, especially for those women with blood sugars that are difficult to control or who experience nocturnal hypoglycemia;
 however, continuous glucose monitoring systems need additional study as part of larger, randomized trials.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0111-9Authors
		J. Seth Hawkins, University of California, Irvine Department of Obstetrics &amp; Gynecology 101 The...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3422258</comments>
            <pubDate>Mon, 29 Mar 2010 17:15:18 +0100</pubDate>
            <guid isPermaLink="false">3422258</guid>        </item>
        <item>
            <title>New Insights on Glucose Pathophysiology in Gestational Diabetes and Insulin Resistance</title>
            <link>http://www.medworm.com/index.php?rid=3422259&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9l1773h885516226%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during
 pregnancy. The definition of GDM does not preclude the possibility that unrecognized glucose intolerance may have existed
 before the pregnancy, and the definition applies whether insulin, oral antidiabetic agents, or dietary modification is used
 for treatment. Approximately 7% of all pregnancies in the United States are complicated by gestational diabetes resulting
 in more than 200,000 cases annually, but the prevalence ranges from 1% to 14% of all pregnancies depending on the population
 studied and the diagnostic tests used. Despite the better detection of GDM and recognition of its adverse consequences for
 mother and baby in many countries, ...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3422259</comments>
            <pubDate>Mon, 29 Mar 2010 17:15:17 +0100</pubDate>
            <guid isPermaLink="false">3422259</guid>        </item>
        <item>
            <title>Are Analogue Insulins Superior to Human Insulin in Clinical Practice?</title>
            <link>http://www.medworm.com/index.php?rid=3409535&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fym77033684135l05%2F</link>
            <description>This article examines the literature over a 2-year period, focusing on studies directly comparing analogue and human
 insulin in controlled clinical trials and large observational studies documenting the introduction of, or change to, analogue
 insulin in clinical practice. Findings indicate that analogues provide objective benefits that include improved glycemic control,
 lower risk of hypoglycemia, lower glucose variability, and (for insulin detemir) reduced weight gain. Recent data with analogues
 also explore their safety and efficacy in special patient groups such as children and adolescents. These data complement increasing
 evidence that analogues offer improved acceptability and accessibility to people with diabetes.
 
 
	Content Type Journal ArticleDOI 10.1007/s11892-010-0104-8Aut...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3409535</comments>
            <pubDate>Thu, 25 Mar 2010 19:09:20 +0100</pubDate>
            <guid isPermaLink="false">3409535</guid>        </item>
        <item>
            <title>Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics</title>
            <link>http://www.medworm.com/index.php?rid=3409536&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx33472k3606857h6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Patients with schizophrenia are at increased risk for developing the metabolic syndrome or its individual components due to
 their lifestyle, suspected genetic predisposition, and exposure to antipsychotic medications that can cause weight gain and
 other metabolic side effects. Despite the availability of clinical guidelines, screening for and monitoring of metabolic problems
 in this patient population continue to be suboptimal. We provide an overview specifically addressing 1) why patients with
 schizophrenia are at increased risk for metabolic problems; 2) how commonly used antipsychotic medications vary in terms of
 their metabolic liability; 3) how to effectively screen for and monitor metabolic problems in patients receiving antipsychotic
 medications; 4) what in...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3409536</comments>
            <pubDate>Thu, 25 Mar 2010 19:09:19 +0100</pubDate>
            <guid isPermaLink="false">3409536</guid>        </item>
        <item>
            <title>Ezetimibe/Simvastatin or Atorvastatin for the Treatment of Hypercholesterolemia in Patients with the Metabolic Syndrome: The VYMET Study</title>
            <link>http://www.medworm.com/index.php?rid=3392048&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F310887075841g085%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11892-010-0107-5Authors
		Jennifer Villa, University of Vermont College of Medicine Diabetes and Metabolism Translational Medicine Unit, Colchester Research Facility 110C 208 South Park Street Colchester VT 05446 USARichard E. Pratley, University of Vermont College of Medicine Diabetes and Metabolism Translational Medicine Unit, Colchester Research Facility 110C 208 South Park Street Colchester VT 05446 USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3392048</comments>
            <pubDate>Sat, 20 Mar 2010 11:11:40 +0100</pubDate>
            <guid isPermaLink="false">3392048</guid>        </item>
        <item>
            <title>Is There a Magic Diet? Studying the Balance of Macronutrients Needed for Best Weight Loss</title>
            <link>http://www.medworm.com/index.php?rid=3380407&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpw26jx8275733624%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11892-010-0105-7Authors
		Anthony L. McCall, University of Virginia Health System Diabetes and Hormone Center of Excellence Box 801407 450 Ray C. Hunt Drive Charlottesville VA 22908 USA
	

	
		Journal Current Diabetes ReportsOnline ISSN 1539-0829Print ISSN 1534-4827 (Source: Current Diabetes Reports)</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380407</comments>
            <pubDate>Wed, 17 Mar 2010 15:51:58 +0100</pubDate>
            <guid isPermaLink="false">3380407</guid>        </item>
        <item>
            <title>Mitigating the Cardiovascular Risk of Anemia in Patients with Type 2 Diabetes and CKD: Does Darbepoetin Help? The TREAT Trial</title>
            <link>http://www.medworm.com/index.php?rid=3360767&amp;cid=s_35932_15_f&amp;fid=35932&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj5u1286028038908%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11892-010-0098-2Authors
		Christi Hayes, State University of New York-Downstate Medical Center and Kings County Hospital Division of Endocrinology, Department of Medicine 450 Clarkson Avenue Box 50 Brooklyn NY 11203 USAAnis Alam, State University of New York-Downstate Medical Center and Kings County Hospital Division of Endocrinology, Department of Medicine 450 Clarkson Avenue Box 50 Brooklyn NY 11203 USAJulie Black-Peart, State University of New York-Downstate Medical Center and Kings County Hospital Division of Endocrinology, Department of Medicine 450 Clarkson Avenue Box 50 Brooklyn NY 11203 USASamy I. McFarlane, State University of New York-Downstate Medical Center and Kings County Hospital Division of Endocrinolo...</description>
            <author>Current Diabetes Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3360767</comments>
            <pubDate>Wed, 10 Mar 2010 16:21:33 +0100</pubDate>
            <guid isPermaLink="false">3360767</guid>        </item>
    </channel>
</rss>

